
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Applications of nanomaterials in head and neck squamous cell carcinoma: current progress and perspectives - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152553848AF44273055384001C108C0D.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="discovernano">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361023/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Discover Nano">
<meta name="citation_title" content="Applications of nanomaterials in head and neck squamous cell carcinoma: current progress and perspectives">
<meta name="citation_author" content="Guo Cheng">
<meta name="citation_author_institution" content="Provincial Key Laboratory of Precision Medicine Research On Head &amp; Neck Cancer, Zhejiang Cancer Hospital, Hangzhou, China">
<meta name="citation_author_institution" content="Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China">
<meta name="citation_author" content="Wentao Li">
<meta name="citation_author_institution" content="Provincial Key Laboratory of Precision Medicine Research On Head &amp; Neck Cancer, Zhejiang Cancer Hospital, Hangzhou, China">
<meta name="citation_author" content="Xin Zhu">
<meta name="citation_author_institution" content="Provincial Key Laboratory of Precision Medicine Research On Head &amp; Neck Cancer, Zhejiang Cancer Hospital, Hangzhou, China">
<meta name="citation_author" content="Chenping Zhang">
<meta name="citation_author_institution" content="Provincial Key Laboratory of Precision Medicine Research On Head &amp; Neck Cancer, Zhejiang Cancer Hospital, Hangzhou, China">
<meta name="citation_publication_date" content="2025 Aug 18">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="141">
<meta name="citation_doi" content="10.1186/s11671-025-04328-1">
<meta name="citation_pmid" content="40824466">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361023/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361023/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361023/pdf/11671_2025_Article_4328.pdf">
<meta name="description" content="Head and neck squamous cell carcinoma (HNSCC) is a common malignant tumor that affects the head and neck area. HNSCC typically has complex clinical symptoms and is detected at a late stage. Therefore, it is quite difficult to give patients the best ...">
<meta name="og:title" content="Applications of nanomaterials in head and neck squamous cell carcinoma: current progress and perspectives">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Head and neck squamous cell carcinoma (HNSCC) is a common malignant tumor that affects the head and neck area. HNSCC typically has complex clinical symptoms and is detected at a late stage. Therefore, it is quite difficult to give patients the best ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361023/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12361023">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s11671-025-04328-1"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/11671_2025_Article_4328.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12361023%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12361023/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12361023/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361023/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-discovernano.png" alt="Discover Nano logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Discover Nano" title="Link to Discover Nano" shape="default" href="https://doi.org/10.1186/s11671-025-04328-1" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Discov Nano</button></div>. 2025 Aug 18;20(1):141. doi: <a href="https://doi.org/10.1186/s11671-025-04328-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s11671-025-04328-1</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Discov%20Nano%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Discov%20Nano%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Discov%20Nano%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Discov%20Nano%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Applications of nanomaterials in head and neck squamous cell carcinoma: current progress and perspectives</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Guo Cheng</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Guo Cheng</span></h3>
<div class="p">
<sup>1</sup>Provincial Key Laboratory of Precision Medicine Research On Head &amp; Neck Cancer, Zhejiang Cancer Hospital, Hangzhou, China </div>
<div class="p">
<sup>2</sup>Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Guo Cheng</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Wentao Li</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Wentao Li</span></h3>
<div class="p">
<sup>1</sup>Provincial Key Laboratory of Precision Medicine Research On Head &amp; Neck Cancer, Zhejiang Cancer Hospital, Hangzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wentao Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Xin Zhu</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Xin Zhu</span></h3>
<div class="p">
<sup>1</sup>Provincial Key Laboratory of Precision Medicine Research On Head &amp; Neck Cancer, Zhejiang Cancer Hospital, Hangzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xin Zhu</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Chenping Zhang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Chenping Zhang</span></h3>
<div class="p">
<sup>1</sup>Provincial Key Laboratory of Precision Medicine Research On Head &amp; Neck Cancer, Zhejiang Cancer Hospital, Hangzhou, China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chenping Zhang</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Provincial Key Laboratory of Precision Medicine Research On Head &amp; Neck Cancer, Zhejiang Cancer Hospital, Hangzhou, China </div>
<div id="Aff2">
<sup>2</sup>Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, China </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 20; Accepted 2025 Aug 6; Collection date 2025 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12361023  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40824466/" class="usa-link">40824466</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Abstract</h3>
<p id="Par1">Head and neck squamous cell carcinoma (HNSCC) is a common malignant tumor that affects the head and neck area. HNSCC typically has complex clinical symptoms and is detected at a late stage. Therefore, it is quite difficult to give patients the best possible care and treatment. Faced with these challenges, nanomaterials are receiving increasing attention in the biomedical field due to their unique structural and physicochemical properties. The application of nanomaterial therapeutics has produced innovative HNSCC treatment options that go beyond the constraints of conventional surgery, radiation therapy, and chemotherapy. In this review, we first reviewed the pathological mechanisms of HNSCC. Subsequently, a detailed introduction to nanomaterials was given, including their classification and definition. Then, the use of nanomaterials in the diagnosis and therapy of HNSCC was discussed, and incorporating the perspective of organoids and clinical trials to increase the feasibility of nanomaterial applications. In addition, we also reviewed the advantages and disadvantages of nanomaterials, proposed the idea of nanomaterial design, looking at how these properties may be used to improve our understanding and treatment of HNSCC. The present approaches for detecting and treating HNSCC can be improved by integrating the special qualities of nanomaterials with the available therapeutic modalities. This will eventually enhance patient outcomes in the battle against this highly invasive malignant tumor.</p></section><section id="sec2"><h3 class="pmc_sec_title">Graphical abstract</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12361023_11671_2025_4328_Figa_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55b/12361023/4bdade78c71a/11671_2025_4328_Figa_HTML.jpg" loading="lazy" id="d33e172" height="368" width="708" alt="graphic file with name 11671_2025_4328_Figa_HTML.jpg"></a></p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par3">Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, with 89,000 new cases reported in 2018 and an expected increase of 30% by 2030 [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. This type of cancer is characterized by its aggressive nature and is often identified at advanced stages. It is marked by rapid recurrence and metastasis, contributing to a generally poor prognosis [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. The increased prevalence of HNSCC is directly linked to well-known risk factors, such as excessive alcohol use, tobacco use, and human papillomavirus (HPV) infection [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. The disease affects the salivary glands, pharynx, larynx, and oral cavity, with Oral Squamous Cell Carcinoma (OSCC) identified as the most common subtype [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>].</p>
<p id="Par4">Surgical tumor removal is usually the first step in the standard treatment of HNSCC. Depending on the stage of the disease, radiation therapy or chemotherapy may then be administered [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Despite recent improvements in medical technology, such as sophisticated radiation treatments, improved surgical methods, and the use of novel chemotherapeutic medications. However, the mortality rate for HNSCC remains between 40 and 50% [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. The severe possibilities of disease recurrence, metastasis, or a mix of both for more than 65% of HNSCC patients [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Traditional remedies frequently result in a number of grave side effects. The quality of life can be greatly impacted by conditions including mutism, ageusia, xerostomia, facial nerve paralysis, and facial deformity [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. These challenges highlight the urgent need to develop new approaches to improve the diagnosis and treatment of HNSCC.</p>
<p id="Par5">Thus far, a wide range of medical problems have been the subject of intensive research on the application of nanomaterials, with oncology receiving particular attention [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. The development of nanotechnology has greatly accelerated the advancement of medicine [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Many different types of nanomaterials, including carbon-based, organic, inorganic, and composite materials, have been used to develop novel cancer treatment approaches [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. This change has made it easier to understand cancer more comprehensively and opened up new avenues for innovative therapeutic approaches. Therefore, the development of novel therapies for HNSCC is being fueled by the thorough understanding of the disease that is being attained through a variety of nanomaterial-based therapeutic techniques.</p>
<p id="Par6">In this paper, we initially reviewed the pathological mechanisms underlying HNSCC. We proceed with a comprehensive overview of nanomaterials, delineating their classifications and definitions. Following this, we summarized the unique properties of nanomaterials and their wide range of applications in the comprehensive treatment and diagnosis of HNSCC, highlighting how these advanced materials can revolutionize current approaches. By integrating the perspectives of organoids and clinical trials, we have enhanced the feasibility and practicality of employing nanomaterials in clinical settings. Moreover, we proposed innovative ideas of nanomaterial design, discussed the current issues that nanomaterials are facing and provided some hope for their future advancement. Finally, we have critically assessed the advantages and disadvantages of nanomaterials, recognizing their potential to transform HNSCC treatment while acknowledging the challenges that lie ahead. There are high hopes for the creative application of nanomaterials in HNSCC treatment. Even if there are still difficulties, it is predicted that further research and development will result in revolutionary solutions that might greatly enhance patient outcomes.</p></section><section id="Sec2"><h2 class="pmc_sec_title">The pathological mechanism of HNSCC</h2>
<p id="Par7">HNSCC arises from mucosal epithelial cells lining critical anatomical structures such as the mouth, pharynx, larynx and sinus [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. The pathological mechanisms of HNSCC are multifaceted and complex, involving a cascade of molecular and cellular alterations that drive the transformation of normal mucosal epithelial cells into malignant cells. This process is characterized by a cascade of genetic mutations, epigenetic modifications, and dysregulation of cellular signaling pathways [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>], which together orchestrate the shift from healthy to cancerous states. The complexity of these mechanisms underscores the need for a comprehensive understanding of the molecular landscape of the disease, which is essential for the development of effective diagnostic and therapeutic strategies (Fig. <a href="#Fig1" class="usa-link">1</a>).</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12361023_11671_2025_4328_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d55b/12361023/d11f27fd0f5f/11671_2025_4328_Fig1_HTML.jpg" loading="lazy" id="d33e247" height="634" width="708" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Comprehensive pathological mechanism of HNSCC</p></figcaption></figure><section id="Sec3"><h3 class="pmc_sec_title">Histological progress</h3>
<p id="Par8">The hallmark of HNSCC is a range of increasing histological alterations, starting with epithelial cell hyperplasia. A rise in cell counts without loss of regular cellular architecture characterizes this early stage. Then, as the condition progresses, the dysplasia is classified as mild, moderate, or severe, each representing a different degree of cellular disorder and departure from normal structure and function. When aberrant cells with a malignant character are restricted to the initial location of epithelial tissue, a condition known as carcinoma in situ might develop if these precancerous alterations are not treated. Eventually, this may result in invasive carcinoma, a major progression in the severity and complexity of the disease, when the cancer has broken through the basement membrane and started to invade the surrounding tissues [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>].</p></section><section id="Sec4"><h3 class="pmc_sec_title">Genetic changes</h3>
<p id="Par9">HNSCC is linked to a high degree of genetic instability, which frequently shows up as the acquisition or loss of certain chromosomal regions. For example, a frequent occurrence during the shift from normal head and neck epithelial mucosa to hyperplasia is the loss of the 9p21 area. This area is important because it contains tumor suppressor genes (TSGs) such ARF, which encodes p14, a p53 stabilizer, and CDKN2A (cyclin dependent kinase inhibitor 2A), which produces the CDK4 and CDK6 inhibitor p16INK4A [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Further development into dysplasia and carcinoma is linked to the sequential loss of additional chromosomal regions, including 3p21, 17p13, 11q13, 13q21, 14q32, 6p, 8, 4q27, and 10q23. These regions contain genes that are essential for controlling the cell cycle, apoptosis, and cell adhesion, and the loss of 6p, 8, 4q27, and 10q23 is indicative of invasive carcinoma [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. These chromosomal anomaly investigations highlight the likelihood that more than one genetic change is required for the entire transition to invasive HNSCC [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>].</p></section><section id="Sec5"><h3 class="pmc_sec_title">Epigenetic changes</h3>
<p id="Par10">Epigenetic modifications, in addition to genetic mutations, are essential to the carcinogenesis of HNSCC. Together with localized hypermethylation, these cancers have global hypomethylation of DNA. Important TSGs have specific promoter regions affected by hypermethylation, which results in the downregulation or silence of these genes. Affected genes include CDKN2A, which encodes the cell cycle inhibitor p16INK4A, O6-methylguanine-DNA methyltransferase (MGMT), a gene associated in cell adhesion, and DCC, a gene implicated in methylation damage repair [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>–<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. The expression of genes that regulate cell cycle progression, apoptosis, and cellular responses to DNA damage is influenced by this epigenetic reprogramming, which is a crucial aspect of the molecular alterations in HNSCC. The disease’s onset and course are greatly aided by the dysregulation brought on by these epigenetic changes.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Signaling pathways</h3>
<p id="Par11">Furthermore, the dysregulation of signaling pathways is a hallmark of HNSCC. One of the pathways in this illness that is most commonly changed is the PI3K-AKT-mTOR pathway, which is essential for supporting cell survival and proliferation [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. In HNSCC, the STAT3 pathway is frequently overexcited, promoting the production of genes that mediate immunosuppression and aid in cell growth and survival, including VEGF, IL-6, IL-10, and TGFβ. In addition, hyperactivation of STAT3 signaling has been linked to mutations in genes producing protein tyrosine phosphatase receptors, notably PTPRT and PTPRD [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. These mutations can lead to the continuous activation of STAT3, fostering a tumor-promoting environment. The WNT-β-catenin pathway is an additional oncogenic signaling pathway that plays a substantial role in the development and advancement of HNSCC, underscoring the intricate nature of the signaling networks responsible for this cancer [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>].</p>
<p id="Par12">Understanding these intricate pathological mechanisms is crucial for the development of targeted therapies and personalized treatment strategies for HNSCC. By dissecting the molecular underpinnings of this disease, researchers and clinicians can better tailor therapies to address the specific genetic and epigenetic aberrations present in individual tumors, thereby improving treatment outcomes and patient prognosis.</p></section></section><section id="Sec7"><h2 class="pmc_sec_title">The overview of nanomaterials</h2>
<p id="Par13">The concept of “nanomaterials” was first articulated by the European Commission in a recommendation issued in 2011 [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. Nanomaterials refer to a wide range of materials with structural dimensions ranging from 1 to 100 nm [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. A pivotal attribute of nanomaterials is that they possess at least one dimension within the nanometer range [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Consequently, any material satisfying this criterion is classified as a nanomaterial.</p>
<p id="Par14">The history of nanomaterials is both extensive and fascinating, with roots that extend far back into antiquity [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. There are two types of nanomaterials, natural nanomaterials, which are produced unintentionally and belong to the environment, and artificial nanomaterials, which are composed for a defined purpose through systematic synthesis or fabrication processes. Artificial nanomaterials are classified into four main categories, carbonaceous, organic, inorganic, and composite-based nanomaterials (Table <a href="#Tab1" class="usa-link">1</a>).</p>
<section class="tw xbox font-sm" id="Tab1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Advantages and disadvantages of different types of nanomaterials</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Category</th>
<th align="left" colspan="1" rowspan="1">Examples</th>
<th align="left" colspan="2" rowspan="1">Advantages</th>
<th align="left" colspan="1" rowspan="1">Disadvantages</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Natural nanomaterials</td>
<td align="left" colspan="1" rowspan="1">
<p>Nanodiamonds [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]</p>
<p>Spider silk [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]</p>
<p>Damascus steel [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Biocompatibility: Natural nanomaterials typically have good biocompatibility because they exist in nature and are compatible with living organisms</p>
<p>Environmentally friendly: They are usually environmentally friendly because they naturally degrade and do not produce persistent pollutants</p>
</td>
<td align="left" colspan="2" rowspan="1">
<p>Limited control: The size, shape, and properties of natural nanomaterials may be difficult to control, limiting their industrial applications</p>
<p>Scalability: As they are naturally generated, they may be difficult to produce on a large scale to meet industrial needs</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Carbonaceous nanomaterials</td>
<td align="left" colspan="1" rowspan="1">
<p>Carbon nanotubes [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]</p>
<p>Fullerene [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]</p>
<p>Carbon dots [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]</p>
<p>Graphene [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Mechanical strength: It has extremely high strength and toughness</p>
<p>Conductivity: Excellent electrical conductor, suitable for electronic devices</p>
<p>Thermal management: has excellent thermal conductivity</p>
</td>
<td align="left" colspan="2" rowspan="1">
<p>Potential toxicity: May pose a risk to the environment and human health</p>
<p>Manufacturing cost: The production process may be costly</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Organic nanomaterials</td>
<td align="left" colspan="1" rowspan="1">
<p>Chitosan Nanoparticles [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]</p>
<p>Silk Fibroin Nanoparticles [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]</p>
<p>PLGA Nanoparticles [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]</p>
<p>Dendrimers [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>] and Liposomes [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Multifunctionality: Nanocomposite materials with multiple functions can be designed</p>
<p>Biodegradability: Some organic based nanomaterials are biodegradable</p>
</td>
<td align="left" colspan="2" rowspan="1">
<p>Stability issue: may be unstable in certain environments</p>
<p>Processing difficulty: Nanoprocessing of organic materials may be challenging</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Inorganic nanomaterials</td>
<td align="left" colspan="1" rowspan="1">Metal Nanoparticles [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>] Metal Oxide Nanoparticles [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]</td>
<td align="left" colspan="1" rowspan="1">
<p>Catalytic activity: commonly used as a catalyst to increase the rate of chemical reactions</p>
<p>Optical properties: It has unique light absorption and emission characteristics</p>
</td>
<td align="left" colspan="2" rowspan="1">
<p>Environmental impact: may have long-term impacts on the ecosystem</p>
<p>Health risk: Inhaling these particles may be harmful to health</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Composite-based nanomaterials</td>
<td align="left" colspan="1" rowspan="1">
<p>Non-polymer composite nanomaterials [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]</p>
<p>Polymer nanocomposites [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Performance synergy: Combining the advantages of different materials, such as strength, conductivity, and biocompatibility</p>
<p>Multifunctional integration: It can achieve multiple functions in a single system</p>
</td>
<td align="left" colspan="2" rowspan="1">
<p>Complexity: The design and manufacturing process may be more complex</p>
<p>Cost issue: may involve more expensive production technologies</p>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec8"><h2 class="pmc_sec_title">The application of nanomaterials in HNSCC</h2>
<section id="Sec9"><h3 class="pmc_sec_title">Nanomaterials for diagnosis</h3>
<p id="Par15">Nanomaterials have significant diagnostic potential due to their high surface-to-volume ratio and quantum confinement effects. A major challenge for surgeons is to accurately delineate tumor boundaries from healthy tissue [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. To address this, functionalized nanomaterials, such as gold nanoparticles (AuNPs), have been developed to specifically target tumor tissues, demarcate normal tissue boundaries, enable targeted molecular imaging, facilitate intraoperative margin identification, and monitor post-treatment prognosis in HNSCC [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Spectral cancer diagnosis using AuNPs has shown promise. Xue et al. [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>] exposed serum samples from patients with OSCC and mucoepidermoid carcinoma to AuNPs, comparing them with samples from healthy blood donors. Using surface-enhanced Raman scattering (SERS) analysis, they achieved a sensitivity of 80% and specificity of 84% in distinguishing nucleic acids and certain proteins in patient serum. These findings indicated that this technique holds potential for early OSCC diagnosis [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>] and could be applied to the TNM (tumor, lymph node, and metastasis) classification system for OSCC based on serum SERS characteristics.</p>
<p id="Par16">Magnetic resonance imaging (MRI) is a widely used non-invasive imaging technique for diagnostic purposes, valued for its high spatial resolution, non-ionizing radiation, and excellent tissue penetration [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. However, traditional MRI alone often falls short in providing satisfactory tumor tissue recognition, limiting its application. To address this limitation, contrast agents can be employed to enhance the resolution of MRI under various clinical conditions, specifically designed to differentiate between tumors and normal tissues [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. Nanoparticle-based contrast agents have emerged as powerful tools for in vivo imaging enhancement. Numerous MRI contrast agents utilizing nanomaterials have been investigated to selectively amplify tumor signals. For instance, Zheng et al. [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>] developed a redox-activated nanostructure for diagnosis and treatment of OSCC, constructing dual-valence cobalt oxide (DV-CO) nanospheres. These nanospheres serve as contrast agents for MRI, exhibiting enhanced transverse and longitudinal relaxation upon glutathione (GSH) release and redox Co<sup>3+</sup>/Co<sup>2+</sup> conversion in acidic conditions, thereby enabling self-enhancement of T1/T2-weighted MR imaging. DV-CO also demonstrates characteristics of intracellular GSH consumption and hydroxyl radical (•OH) generation through Fenton reaction, thereby enhancing the efficacy of chemodynamic (CD) therapy. DV-CO exhibits effective near-infrared laser-induced photothermal (PT) effects, demonstrating the synergistic inhibitory influence of PT-CD on OSCC tumor cells. Furthermore, the tumor-specific self-enhanced MR imaging capability of DV-CO was further examined in subcutaneous and orthotopic OSCC mice, confirming the therapeutic efficacy of DV-CO in orthotopic OSCC models.</p>
<p id="Par17">Nanomaterial-based biosensor manufacturing technology offers a simplified and enhanced approach for diagnosing oral cancer (OC) or OSCC. Determining the incidence of oral potentially malignant disorders (OPMDs) or OSCC based on a single biomarker is challenging in clinical settings. Therefore, detecting a variety of biomarkers becomes essential for obtaining a more accurate prognosis. This multiplex detection can be achieved by immobilizing different target-specific biometric probes on the surface of nanomaterials. Nanoparticle-based scaffolds, benefiting from their increased surface area-to-volume ratio and quantum confinement effect, enhance chemical reactivity and stability while accommodating multiple ligands. The biosensing capability of nano-biosensors has been successfully demonstrated in minimally invasive or completely non-invasive OSCC detection on clinical platforms [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>, <a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. For instance, fluorescence-based nanostructures have been developed to detect specific HPV-DNA, exhibiting high specificity against HIV, influenza, HPV, and HBV-specific oligonucleotides. Notably, the system demonstrated high sensitivity in detecting HPV-16E6 in clinical samples from patients diagnosed with HNSCC [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. Functional nanomaterials have found widespread use in nano-biosensor platforms for detecting clinically relevant biomolecules in biological fluids, leveraging their unique properties. By combining biosensor technology with nanotechnology, it becomes possible to overcome limitations such as low sensitivity and instability [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>], thus paving the way for significant advancements in OSCC detection and diagnosis (Table <a href="#Tab2" class="usa-link">2</a>).</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Nanomaterials for diagnosis in HNSCC</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Nanomaterials</th>
<th align="left" colspan="1" rowspan="1">Function</th>
<th align="left" colspan="1" rowspan="1">Detection method</th>
<th align="left" colspan="1" rowspan="1">Sample type</th>
<th align="left" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Gold nanoparticles</td>
<td align="left" colspan="1" rowspan="1">Test serum samples for early diagnosis and TNM classification</td>
<td align="left" colspan="1" rowspan="1">Surface-enhanced Raman spectroscopy (SERS)</td>
<td align="left" colspan="1" rowspan="1">Serum sample from patients with primary OSCC</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DV-CO</td>
<td align="left" colspan="1" rowspan="1">Serve as contrast agents to enhance the resolution of MRI</td>
<td align="left" colspan="1" rowspan="1">MRI</td>
<td align="left" colspan="1" rowspan="1">CAL-27 and HN-6 cells/BALB/c athymic nude mice</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fluorescence-based nanostructures</td>
<td align="left" colspan="1" rowspan="1">Detect HPV-16E6 in clinical samples</td>
<td align="left" colspan="1" rowspan="1">Polymerase chain reaction (PCR)</td>
<td align="left" colspan="1" rowspan="1">Serum samples obtained from eight patients with histologically confirmed HNSCC</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Colloidal gold nanoparticles</td>
<td align="left" colspan="1" rowspan="1">Conjugate to anti-epidermal growth factor receptor (EGFR) for imaging</td>
<td align="left" colspan="1" rowspan="1">Confocal reflectance microscopy</td>
<td align="left" colspan="1" rowspan="1">Cell samples</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Surface plasmon resonant gold nanoparticles</td>
<td align="left" colspan="1" rowspan="1">Enhance contrast in optical coherence tomography (OCT) images</td>
<td align="left" colspan="1" rowspan="1">OCT</td>
<td align="left" colspan="1" rowspan="1">Hamster oral dysplasia model</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Molecularly activated plasmonic nanosensors (MAPS)</td>
<td align="left" colspan="1" rowspan="1">
<p>Target to the EGFR and</p>
<p>guide spectroscopic photoacoustic (sPA) imaging</p>
</td>
<td align="left" colspan="1" rowspan="1">Photoacoustic imaging</td>
<td align="left" colspan="1" rowspan="1">A metastatic murine model of oral squamous cell carcinoma</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Folic acid gold nanoparticles linked cysteamine</td>
<td align="left" colspan="1" rowspan="1">Target imaging in vivo</td>
<td align="left" colspan="1" rowspan="1">Computed tomography (CT)</td>
<td align="left" colspan="1" rowspan="1">Nude mice</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gold nanorods</td>
<td align="left" colspan="1" rowspan="1">Map tumor margins in squamous cell carcinoma</td>
<td align="left" colspan="1" rowspan="1">Air scanning electron microscopy</td>
<td align="left" colspan="1" rowspan="1">Tissue sections of squamous cell carcinoma</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">A novel photoelectrochemical biosensor</td>
<td align="left" colspan="1" rowspan="1">monitor multiplexed DNA in cancer cells</td>
<td align="left" colspan="1" rowspan="1">Photoelectrochemical diagnostic devices</td>
<td align="left" colspan="1" rowspan="1">DNA in cancer cells</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec10"><h3 class="pmc_sec_title">Nanomaterials for treatment</h3>
<section id="Sec11"><h4 class="pmc_sec_title">Chemotherapy</h4>
<p id="Par18">In the head and neck region, the oral cavity is highly susceptible to malignancies, with OSCC accounting for approximately 80–90% of cases. While radical resection remains the primary treatment option, chemotherapy plays a crucial role as an adjuvant therapy for patients with advanced/recurrent OSCC or those who cannot undergo surgery. In recent years, the availability of chemotherapy regimens has expanded rapidly. However, the 5-year survival rate for advanced/recurrent OSCC remains below 30% [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. The tumor microenvironment, specifically hypoxia and acid conditions, significantly contribute to the poor efficacy of chemotherapeutic drugs in OSCC treatment. To address this issue, Chen et al. [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>] synthesized a series of Zn<sub>1-x</sub>Mg<sub>x</sub>Fe<sub>2</sub>O<sub>4</sub> nanomaterials exhibiting enzyme-like properties, including catalase (CAT)-like, peroxidase (POD)-like, and glutathione (GSH)-like activities. Among them, Zn<sub>0.4</sub>Mg<sub>0.6</sub>Fe<sub>2</sub>O<sub>4</sub> demonstrated the most favorable characteristics. It effectively increased oxygen content, rectified the anoxic microenvironment within OSCC tumors, reduced OSCC chemotherapy tolerance, and improved chemotherapy outcomes. The nano-enzyme exhibited POD-like activity and selectively targeted tumor cells in the acidic tumor microenvironment while preserving normal cell integrity. Zn<sub>0.4</sub>Mg<sub>0.6</sub>Fe<sub>2</sub>O<sub>4</sub> significantly enhanced the efficacy of Doxorubicin (DOX) chemotherapy in OSCC treatment while reducing cardiotoxicity. Therefore, Zn<sub>0.4</sub>Mg<sub>0.6</sub>Fe<sub>2</sub>O<sub>4</sub> holds promise as a novel chemical sensitizer in OSCC therapy.</p>
<p id="Par19">In addition to OSCC cells, stromal cells play a significant role in tumor progression by creating anoxic and acidic microenvironments that promote OSCC growth. Among the stromal cell populations, cancer-associated fibroblasts (CAFs) are the dominant contributors [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>–<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>]. CAFs play a pivotal role in the development and progression of malignant tumors, including OSCC, making them a promising target for therapeutic intervention. In a study by Xia et al. [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>], gold nanoparticles (GNPs) exhibited remarkable size-dependent anti-CAFs properties, with the smallest GNPs outperforming their larger counterparts. Exposure to GNPs led to a decrease in a group of proteins and cytokines responsible for the invasive growth of OSCC cells in CAFs derived from OSCC patients. Furthermore, in vivo experiments demonstrated that GNPs with a diameter of 3 nm effectively inhibited OSCC tumor growth, presenting a novel clinical approach to OSCC treatment.</p></section><section id="Sec12"><h4 class="pmc_sec_title">Radiotherapy</h4>
<p id="Par20">Radiation oncology is a standard therapeutic approach for treating HNSCC. While its effectiveness is notable, there have been reports of radiation resistance, as well as the occurrence of side effects such as mucositis and xerostomia. In the field of radiotherapy, gold nanoparticles (AuNPs) have emerged as potential sensitizers capable of enhancing the radiation response of tumors while minimizing adverse effects. The high atomic number of AuNPs results in strong photoelectric absorption and secondary electron emission when exposed to gamma rays or X-rays. Studies have revealed that oxidative stress, DNA damage induction, cell cycle arrest, and potential interference with the bystander effect are the primary mechanisms underlying the biological response of cells to AuNPs’ radiosensitization [<a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>]. Additionally, AuNPs can amplify the effects of photons and particles that induce ionizing radiation.</p>
<p id="Par21">To maximize the benefits of radiotherapy (RT), efficient delivery and internalization of AuNPs within cancer cells are crucial. AuNPs enter cells through receptor-mediated endocytosis [<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>], making their combination with radiotherapy a comprehensive treatment approach [<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]. One proposed therapeutic platform involves a nanocomposite that integrates cisplatin-functionalized AuNPs, demonstrating remarkable tumor suppression in vivo following irradiation and exhibiting potential as a contrast agent for computed tomography (CT) imaging [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. In another study utilizing an HNSCC cell line model, the combination of AuNPs with X-ray radiation or an epidermal growth factor inhibitor displayed enhanced cytotoxicity, reduced cell proliferation, and increased apoptosis, underscoring their synergistic effects [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>].</p>
<p id="Par22">The enhanced radiosensitivity of AuNPs at kiloelectron volt (KeV) energy levels surpasses that of the clinical megavolt (MV) used in RT. In light of this, Piccolo et al. [<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>] devised a diamond target beam (DTB) system to augment the quantity of low-energy photons both in vitro and in vivo using head and neck tumor cell lines and zebrafish xenotransplantation models. In comparison to standard RT, the viability of HNSCC cells decreased, and tumor cell eradication increased in zebrafish xenotransplantation experiments. These effects were primarily attributed to DNA double-strand breaks and the elevated generation of ROS, including superoxide anions, hydroxyl radicals, and hydrogen peroxide. These preclinical findings indicated the significant potential of AuNPs in advancing radiation oncology and suggest that clinical benefits for patients may be realized in the coming years.</p></section><section id="Sec13"><h4 class="pmc_sec_title">PDT</h4>
<p id="Par23">Surgery-based comprehensive therapy, supplemented by radiotherapy and chemotherapy, has long been the primary approach for treating HNSCC. However, functional tissue damage to the tongue can result in significant dysfunction and psychological trauma for patients [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>]. Photodynamic therapy (PDT), with its non-invasive nature, spatial–temporal controllability, and repeatability, has emerged as a viable option in the field of head and neck tumor treatment. Oral cancer, given its relatively superficial location and high clinical maneuverability, is particularly suitable for clinical application of PDT. PDT, an established non-invasive treatment method with a history of over a century, has been extensively studied in numerous clinical trials. These trials have demonstrated that PDT not only preserves the oral structure, function, and appearance of OSCC patients but also minimizes side effects without causing permanent or systemic toxicity [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>]. The fundamental principle of PDT lies in the introduction of photosensitizers (PSs) into tumor tissues, followed by the application of light at specific wavelengths. PSs interact with oxygen and light to generate phototoxic molecules that directly induce cancer cell death. Upon photoactivation, PSs convert intracellular oxygen into cytotoxic ROS, such as singlet oxygen (<sup>1</sup>O<sub>2</sub>), leading to apoptosis, necrosis, autophagy [<a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>], and immunogenic cell death (ICD). AuNPs coated with PSs, such as porphyrin [<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>], have shown promise in the treatment of superficial epidermoid carcinoma and are recommended for the management of mucosal and tongue tumors.</p>
<p id="Par24">Duman et al. [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>] devised a nanocomposite by encapsulating gold nanorods (GNRs) within polyacrylic acid (PAA), which were electrostatically coupled with cationic porphyrin TMPyP. The photosensitizing effect of this approach was evaluated in two-dimensional and three-dimensional models of HNSCC. These cellular systems were exposed to 420 nm wavelengths with a peak emission of 7mWcm-1 for a duration of 10 min. Remarkable phototoxicity was observed, resulting in a decrease in tumor cell proliferation in both models. In another investigation, HNSCC cell lines were subjected to AuNPs coated with 5-aminolevulinic acid, followed by irradiation with a red-light emitting diode (LED) source at 621 nm for PDT. This technique induced tumor cell apoptosis and inhibited the mRNA and protein expression of β-catenin, c-Myc, Cyclin D1 [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>].</p>
<p id="Par25">PDT, as a promising non-invasive therapy, has garnered considerable attention in the field of tumor treatment. However, its therapeutic efficacy is hampered by the limited absorptive capacity of tumor cells and the imperfect mechanisms of damage repair. In an effort to enhance the effectiveness of PDT, Dai et al. [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>] developed a biomimetic nanomaterial called PCN-CQ@CCM, which is coated with oral cancer cell membrane. This novel approach aims to establish targeted therapeutic functions and autophagy inhibition strategies. By utilizing the metal–organic skeleton material PCN-224 as the carrier, the autophagy inhibitor chloroquine (CQ) was loaded and then coated with OSCC cell membrane. Upon entering the bloodstream, the nanoparticles benefit from the surface camouflage effect provided by the oral cancer cell membrane, enabling them to evade the immune system. This camouflage effect also endows the nanoparticles with homologous targeting capabilities, thereby minimizing potential systemic side effects. Following activation by a 660 nm laser, the produced ROS induce apoptosis via mitochondrial damage. The release of CQ further enhances the lethality of ROS by effectively inhibiting protective autophagy. This non-invasive, targeted, and spatiotemporally controllable treatment modality maximizes the preservation of normal tissues and organs surrounding the tumor, while significantly improving the preservation and functional maintenance of the oral and jaw system affected by oral cancer.</p></section><section id="Sec14"><h4 class="pmc_sec_title">PTT</h4>
<p id="Par26">Photothermal therapy (PTT) is an emerging and promising treatment modality that utilizes photothermal conversion agents (PTAs) to generate sufficient heat under near-infrared (NIR) light for tumor cell ablation [<a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>, <a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>]. It has been reported that temperatures as high as 41 °C can induce vasodilation and enhance blood perfusion in tumor tissues, thereby triggering a heat shock response in cells. Temperatures exceeding 46 °C result in irreversible cellular damage [<a href="#CR82" class="usa-link" aria-describedby="CR82">82</a>]. The principal wavelength used in PTT is near-infrared light because of its remarkable tissue penetration, minimal biological tissue absorption, dispersion, and remote control capabilities [<a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>]. PTAs serve as a vital component in PTT, acting as the medium for converting light energy into heat energy. Through targeted recognition technology, PTAs are injected into the human body and accumulate at the tumor site. Upon irradiation with near-infrared light, the absorbed light energy is efficiently converted into heat energy, subsequently elevating the temperature within the lesion area and eradicating cancer cells [<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>].</p>
<p id="Par27">Metal nanoparticles, such as gold nanoparticles (AuNPs), have garnered significant attention as PTT agents due to their unique optical properties, particularly their strong near-infrared (NIR) absorption. In a study by Zhang et al. [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>], gold nanorods (GNRs) coated with EGFR monoclonal antibody were synthesized. The previously treated laryngeal cancer cells were then irradiated with an 808 nm NIR laser for 6 min, resulting in a local average temperature of 50 °C and the induction of apoptosis-mediated cell death. Likewise, cetuximab-coated GNRs along with human anti-EGFR antibody EGFR-hIgG1 were employed in the HNSCC cell line CAL27. Following a 24 h treatment period, the cells were exposed to a 2 min dose of a continuous wave (CW) diode laser operating at 1064 nm and with a power density of 2 Wcm-2. It was discovered that a rise in local temperature was linked to a considerable loss of tumor cells, indicating that the use of GNRs in conjunction with targeted EGFR has potential as a successful PTT strategy [<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>].</p>
<p id="Par28">Photoacoustic imaging (PAI) plays a pivotal role in the diagnosis and evaluation of OSCC, particularly in tumor localization and the detection of metastatic lymph nodes. PAI is an emerging non-ionizing and non-invasive diagnostic technique that enables high-resolution and depth-specific tissue visualization [<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>]. An additional notable characteristic of PAI is its potential for integrated diagnosis and treatment, such as PTT. Zeng et al.’s paper described the effective development of DOX-AuNRs@mSiO2-HA, a new mesoporous silica composite coated with gold nanoparticles [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>]. This composite exhibited ultra-high photoacoustic imaging signals, remarkable photothermal conversion efficiency, and excellent drug loading capacity. The gold nanoparticles were coated with mesoporous silica featuring large pores, while doxorubicin hydrochloride—an effective anticancer drug—was loaded into the mesoporous silica via electrostatic interactions, specifically van der Waals forces. The attachment of hyaluronic acid (HA) molecules to the AuNRs@mSiO<sub>2</sub> nanoparticles occurred through amide bonds. The resulting gold nanomaterials demonstrated exceptional photothermal conversion efficiency and generated high-resolution photoacoustic signals, making them suitable for tumor targeting and PAI-guided photothermal chemotherapy in OSCC.</p></section><section id="Sec15"><h4 class="pmc_sec_title">Immunotherapy</h4>
<p id="Par29">Tumor immunotherapy has emerged as a novel approach for the treatment of primary tumors, capitalizing on the activation of immune cells to recognize and eliminate residual cancer cells. This mechanism holds great promise in reducing tumor metastasis and recurrence, and its success has been demonstrated in clinical practice. In the case of HNSCC, certain immunotherapeutic drugs, including cetuximab and nivolumab, have received approval for treatment. However, these antibodies have inherent limitations when used as standalone therapies for HNSCC. To overcome these limitations, coupling them with gold nanomaterials has been explored to enhance their therapeutic efficacy [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>].</p>
<p id="Par30">Cell stiffness is a fundamental biomechanical characteristic that has garnered increasing attention. Growing evidence suggests that cancer cells exhibit relatively softer and more deformable properties compared to normal cells [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>]. Low cell stiffness is associated with cancer cell adhesion, metastatic potential, and invasiveness, highlighting its relevance to malignant transformation and tumor progression. Changes in cancer cell stiffness play a crucial role in the anti-tumor response and immune evasion, as harder tumor cells display heightened sensitivity to T cell-mediated killing. The biophysical impact of increased cancer cell stiffness enhances their ability to activate cytotoxic lymphocytes, thereby effectively modulating the immune microenvironment within tumors. Consequently, enhancing cancer cell stiffness to improve the efficacy of immunotherapy holds great promise as a potential tumor treatment strategy. In a study conducted by Zhang et al. [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>], a novel carbon nano-enzyme, graphdiyne oxide (GDYO), was synthesized through acid oxidation. In vitro experiments demonstrated that GDYO could enhance the stiffness of tumor cells under laser irradiation, thereby augmenting the cytotoxicity of T cells and the secretion of inflammatory cytokines (IFN-γ and TNF-α). Furthermore, GDYO exhibited inhibitory effects on an OSCC model by combining PDT, and it triggered an anti-tumor immune response mediated by specific cytotoxic T cells. These findings highlight the potential of GDYO in breaking through the barriers of the immunosuppressive tumor microenvironment and enhancing the effectiveness of immunotherapy.</p></section><section id="Sec16"><h4 class="pmc_sec_title">Targeted therapy</h4>
<p id="Par31">In recent years, nanomaterials have made significant progress in developing targeted therapeutic systems for HNSCC. By combining nucleic acid aptamers or antibodies with nanomaterials, precise treatment can be achieved [<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]. Nucleic acid aptamers are single stranded oligonucleotide with high affinity and specificity, capable of specifically binding to target molecules on the surface of tumor cells [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>]. For example, researchers have developed nucleic acid aptamer nanomaterials that bind to EGFR for targeted therapy of HNSCC [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. Antibody-conjugated nanomaterials achieve precise targeting by binding specific antibodies to receptors on the surface of tumor cells. For example, gold nanoparticles conjugated with anti-EGFR antibodies have been developed for PTT in HNSCC. These nanomaterials can generate local high temperatures under NIR light irradiation, thereby inducing tumor cell apoptosis [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. Beyond single targeting strategy, researchers have also developed multifunctional nanomaterials that combine multiple therapeutic approaches. For example, a nano material based on HA modified gold nanorods has been developed for the combined application of photothermal therapy and chemotherapy. These nanomaterials can not only kill tumor cells through photothermal effects, but also further enhance therapeutic effects by loading chemotherapy drugs such as doxorubicin [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]. This multifunctional approach holds great promise for improving treatment outcomes in HNSCC by leveraging the synergistic effects of different therapeutic modalities.</p></section><section id="Sec17"><h4 class="pmc_sec_title">Adjuvant therapy</h4>
<p id="Par32">Tumor invasion and metastasis are critical factors influencing the prognosis of HNSCC, particularly OSCC. They pose significant challenges to effective treatment. In recent years, there has been growing interest in the use of phytochemicals as adjuvants in traditional cancer therapy. Zingerone, a phenolic component found in ginger, is one such phytochemical. This non-volatile and biologically active compound possesses diverse pharmacological properties, including anti-inflammatory, anticancer, and antibacterial effects [<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>]. In a study conducted by Yang et al. [<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>], zingerone nanoparticles (NPs) derived from phytochemical sources were prepared, and their inhibitory effects on invasiveness and metastasis of human OSCC cell lines were investigated. The phytochemical zingerone NPs demonstrated the ability to inhibit the proliferation, migration, and invasion of OSCC cells by targeting and suppressing Akt activity. These findings suggest that zingerone NPs, as a novel and efficient phytochemical-based nanoparticle, hold promise as effective adjuvants in future chemoprophylaxis and cancer treatment for OSCC. Their utilization may improve the side effects, drug resistance, and recurrence associated with traditional cancer therapy (Table <a href="#Tab3" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="Tab3"><h5 class="obj_head">Table 3.</h5>
<div class="caption p"><p>Nanomaterials for treatment in HNSCC</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Nanomaterials</th>
<th align="left" colspan="1" rowspan="1">Purpose</th>
<th align="left" colspan="1" rowspan="1">Function</th>
<th align="left" colspan="1" rowspan="1">In vitro/in vivo model</th>
<th align="left" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Zn<sub>0.4</sub>Mg<sub>0.6</sub>Fe<sub>2</sub>O<sub>4</sub>
</td>
<td align="left" colspan="1" rowspan="1">Chemotherapy</td>
<td align="left" colspan="1" rowspan="1">Rectify the anoxic microenvironment within tumors, reduce chemotherapy tolerance and improve chemotherapy outcomes</td>
<td align="left" colspan="1" rowspan="1">SCC9 cells/BALB/c athymic nude mice</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gold nanoparticles</td>
<td align="left" colspan="1" rowspan="1">Chemotherapy</td>
<td align="left" colspan="1" rowspan="1">Possess size-dependent anti-CAFs properties to inhibit tumor growth</td>
<td align="left" colspan="1" rowspan="1">R-cab and SCC9 cells, cancer-associated fibroblasts and normal fibroblasts/BALB/c athymic nude mice</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AuNPs</td>
<td align="left" colspan="1" rowspan="1">Radiotherapy</td>
<td align="left" colspan="1" rowspan="1">Combine AuNPs with X-ray radiation or an epidermal growth factor inhibitor to enhance cytotoxicity and increase apoptosis</td>
<td align="left" colspan="1" rowspan="1">HSC-3 cells/-</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Diamond target beam (DTB) system</td>
<td align="left" colspan="1" rowspan="1">Radiotherapy</td>
<td align="left" colspan="1" rowspan="1">Increase tumor cell eradication, advance radiation oncology</td>
<td align="left" colspan="1" rowspan="1">FaDu, HSC-3 and Detroit-562 cells/zebrafish xenotransplantation models</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">A nanocomposite by encapsulating gold nanorods (GNRs) within polyacrylic acid (PAA)</td>
<td align="left" colspan="1" rowspan="1">PDT</td>
<td align="left" colspan="1" rowspan="1">
<p>Irradiate with a red-light emitting diode (LED) source at 621nm for PDT</p>
<p>To induce tumor cell apoptosis and inhibit the mRNA and protein expression of β-catenin, c-Myc, Cyclin D1</p>
</td>
<td align="left" colspan="1" rowspan="1">A431 cells/2D monolayer HNSCC models and 3D compressed HNSCC collagen constructs</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PCN-CQ@CCM</td>
<td align="left" colspan="1" rowspan="1">PDT</td>
<td align="left" colspan="1" rowspan="1">Establish targeted therapeutic functions and autophagy inhibition strategies to enhance the effectiveness of PDT</td>
<td align="left" colspan="1" rowspan="1">Cal-27, HeLa, MDA-MB-231, B16, RAW264.7 and HaCaT cells/A nude mouse model of Cal-27 oral squamous cell carcinoma with tumors on its back</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gold nanorods (GNRs) coated with EGFR monoclonal antibody</td>
<td align="left" colspan="1" rowspan="1">PTT</td>
<td align="left" colspan="1" rowspan="1">Treat laryngeal cancer cells with an 808nm NIR laser for 6 min and observe significant tumor cell death</td>
<td align="left" colspan="1" rowspan="1">FaDu and 293T cells/-</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DOX-AuNRs@mSiO<sub>2</sub>-HA</td>
<td align="left" colspan="1" rowspan="1">PTT</td>
<td align="left" colspan="1" rowspan="1">Exhibit ultra-high photoacoustic imaging signals, remarkable photothermal conversion efficiency, and excellent drug loading capacity for tumor targeting and PAI-guided photothermal chemotherapy</td>
<td align="left" colspan="1" rowspan="1">CAL-27 and HOK cells/BALB/c athymic nude mice</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GDYO</td>
<td align="left" colspan="1" rowspan="1">Immunotherapy</td>
<td align="left" colspan="1" rowspan="1">Enhance the stiffness of tumor cells under laser irradiation to improve the efficacy of immunotherapy</td>
<td align="left" colspan="1" rowspan="1">SCC9, HOK and SCC7 cells/C3H mice</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-EGFR scFv human antibody-conjugated immunoliposomes</td>
<td align="left" colspan="1" rowspan="1">Targeted therapy</td>
<td align="left" colspan="1" rowspan="1">Enhance chemotherapeutic efficacy by improving endocytosis and reducing the therapeutic dosages of the drugs</td>
<td align="left" colspan="1" rowspan="1">FaDu and Ca9-22 cells/ Nod/SCID mice</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Targeting Au-HN-1 nanosystems</td>
<td align="left" colspan="1" rowspan="1">Targeted therapy</td>
<td align="left" colspan="1" rowspan="1">Target tongue squamous cell carcinoma for CT imaging and PTT</td>
<td align="left" colspan="1" rowspan="1">SCC9, CAL 27 and SCC15 cells/ nude mice</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Zingerone nanoparticles (NPs)</td>
<td align="left" colspan="1" rowspan="1">Adjuvant therapy</td>
<td align="left" colspan="1" rowspan="1">Target and inhibit Akt activity to suppress OSCC cell and improve the side effects, drug resistance, and recurrence of traditional cancer treatment</td>
<td align="left" colspan="1" rowspan="1">Ca9-22, CAL-27 and SAS cells/-</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section></section><section id="Sec18"><h2 class="pmc_sec_title">The combination of nanomaterials and tumor organoids</h2>
<p id="Par33">Nanomaterials’ application within tumor organoids marks a cutting-edge advancement in oncology. These organoids, which are 3D tumor mimics, serve as invaluable models for probing cancer biology and evaluating treatments [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>]. (Table <a href="#Tab4" class="usa-link">4</a>) By merging nanomaterials with organoids, the research field gains unique advantages for both cancer study and therapy development. Currently, research has been conducted on pancreatic cancer [<a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>], colorectal cancer [<a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>], and breast cancer [<a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>, <a href="#CR96" class="usa-link" aria-describedby="CR96">96</a>] (Table <a href="#Tab5" class="usa-link">5</a>). Yet, within the domain of HNSCC, substantial gaps in knowledge persist, offering numerous avenues for deeper inquiry. The synergy between nanomaterials and cancer organoids holds great potential for advancing our understanding of cancer biology and for the discovery and validation of novel anticancer strategies. As this field continues to evolve, it is expected to contribute significantly to the arsenal of tools available for cancer research and treatment.</p>
<section class="tw xbox font-sm" id="Tab4"><h3 class="obj_head">Table 4.</h3>
<div class="caption p"><p>Application of nanomaterials in HNSCC</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Nanomaterials</th>
<th align="left" colspan="1" rowspan="1">Preparation</th>
<th align="left" colspan="1" rowspan="1">Characterization</th>
<th align="left" colspan="1" rowspan="1">In vivo results</th>
<th align="left" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">DV-CO</td>
<td align="left" colspan="1" rowspan="1">A multifunctional dual-valence cobalt oxide (DV-CO) nanospheres constructed via a solvothermal method</td>
<td align="left" colspan="1" rowspan="1">
<p>Self-enhanced MRI performance</p>
<p>Responsive chemodynamic (CD) properties</p>
</td>
<td align="left" colspan="1" rowspan="1">Delineate the tumor tissue contour through self-enhanced MRI and inhibit tumor growth in an orthotopic OSCC tumor-bearing mouse model</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Zn<sub>0.4</sub>Mg<sub>0.6</sub>Fe<sub>2</sub>O<sub>4</sub>
</td>
<td align="left" colspan="1" rowspan="1">Zn<sub>0.4</sub>Mg<sub>0.6</sub>Fe<sub>2</sub>O<sub>4</sub> nanoenzyme synthesized via a modified co-precipitation method</td>
<td align="left" colspan="1" rowspan="1">
<p>Identify the structural and phase of the nanoenzymes via X-ray diffraction (XRD)</p>
<p>Measure the hydrodynamic diameter and zeta potential of the nanoenzymes via dynamic light scattering (DLS)</p>
<p>Observe the size and morphology of the nanoenzymes via transmission electron microscopy (TEM)</p>
</td>
<td align="left" colspan="1" rowspan="1">The combination of Zn<sub>0.4</sub>Mg<sub>0.6</sub>Fe<sub>2</sub>O<sub>4</sub> nanoenzyme with the chemotherapeutic drug doxorubicin (DOX) significantly reduced tumor volume and mitigated the cardiotoxicity of DOX in a mouse xenograft model</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gold nanoparticles</td>
<td align="left" colspan="1" rowspan="1">Synthesized separately by the DMSA reduction of HAuCl4 and the citrate reduction of HAuCl4</td>
<td align="left" colspan="1" rowspan="1">The gold nanoparticles were characterized by their size, shape, and surface properties</td>
<td align="left" colspan="1" rowspan="1">Inhibit the growth of tumors in vivo demonstrating a significant bystander antitumoral effect</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Diamond target beam (DTB) system</td>
<td align="left" colspan="1" rowspan="1">Synthesize and stabilize with a neutral, water-soluble ligand shell</td>
<td align="left" colspan="1" rowspan="1">TEM was used to investigate the uptake and localization in lysosomes</td>
<td align="left" colspan="1" rowspan="1">Exhibit significantly increased cell death in zebrafish model</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">A nanocomposite by encapsulating gold nanorods (GNRs) within polyacrylic acid (PAA)</td>
<td align="left" colspan="1" rowspan="1">Synthesize and encapsulate with PAA to confer biocompatibility</td>
<td align="left" colspan="1" rowspan="1">The GNRs enhanced the absorption and emission intensity of TMPyP, improving its photodynamic efficiency and fluorescence imaging capability</td>
<td align="left" colspan="1" rowspan="1">GNRs significantly enhanced photodynamic therapy (PDT) and fluorescence imaging in the 3D model</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PCN-CQ@CCM</td>
<td align="left" colspan="1" rowspan="1">The biomimetic nanomaterial PCN-CQ@CCM was developed using the metal–organic framework material PCN-224 as a carrier to load the autophagy inhibitor chloroquine (CQ)</td>
<td align="left" colspan="1" rowspan="1">The nanomaterial was characterized by its ability to evade macrophage phagocytosis due to its biomimetic surface, which also enabled homologous targeting and enhanced uptake by tumor cells</td>
<td align="left" colspan="1" rowspan="1">PCN-CQ@CCM, when activated by a 660 nm laser, triggered apoptosis via mitochondrial damage and further exacerbated the lethal effects of reactive oxygen species (ROS) by inhibiting protective autophagy in vivo experiments</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gold nanoparticles coated with EGFR monoclonal antibody</td>
<td align="left" colspan="1" rowspan="1">Gold nanoparticles were conjugated with epidermal growth factor receptor monoclonal antibodies (EGFRmAb) to create EGFRmAb-AuNPs</td>
<td align="left" colspan="1" rowspan="1">Specifically target cancer cells overexpressing EGFR, such as FaDu hypopharyngeal carcinoma cells, while showing reduced toxicity to non-target cells like 293T cells</td>
<td align="left" colspan="1" rowspan="1">EGFRmAb-AuNPs, when activated by near-infrared light, induced apoptosis in FaDu cells and achieve significant tumor suppression in vivo experiments</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DOX-AuNRs@mSiO<sub>2</sub>-HA</td>
<td align="left" colspan="1" rowspan="1">Synthesize multifunctional nanoparticles composed of hyaluronic acid (HA)-modified gold nanorods (AuNRs) and mesoporous silica</td>
<td align="left" colspan="1" rowspan="1">Exhibit favorable biocompatibility, low cytotoxicity, high drug loading capacity, and strong photoacoustic imaging signals</td>
<td align="left" colspan="1" rowspan="1">The nanoparticles could accumulate rapidly at the tumor sites and achieve complete ablation of tumors when combined with near-infrared laser irradiation</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GDYO</td>
<td align="left" colspan="1" rowspan="1">Graphdiyne oxide (GDYO) was synthesized as the photosensitizer for photodynamic therapy (PDT)</td>
<td align="left" colspan="1" rowspan="1">GDYO was characterized for its phototoxicity using confocal laser scanning microscopy, measurements of membrane cholesterol levels, and assessments of the F-actin cytoskeleton</td>
<td align="left" colspan="1" rowspan="1">GDYO-based PDT significantly inhibited tumor growth and elicited antitumor immune responses through specific cytotoxic T cells in a murine xenograft model</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><section class="tw xbox font-sm" id="Tab5"><h3 class="obj_head">Table 5.</h3>
<div class="caption p"><p>Application of nanomaterials in organoid for cancer strategies</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Nanomaterials</th>
<th align="left" colspan="1" rowspan="1">Cancer type</th>
<th align="left" colspan="1" rowspan="1">Organoid type</th>
<th align="left" colspan="1" rowspan="1">Conclusion</th>
<th align="left" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Tumor-penetrating nanocomplexes (TPNs)</td>
<td align="left" colspan="1" rowspan="1">Pancreatic cancer</td>
<td align="left" colspan="1" rowspan="1">Human pancreatic tumor organoids</td>
<td align="left" colspan="1" rowspan="1">Functional tumor-penetrating delivery of siRNA to pancreatic tumors</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD44-targeted polymer nanoparticles</td>
<td align="left" colspan="1" rowspan="1">Colorectal cancer (CRC)</td>
<td align="left" colspan="1" rowspan="1">CRC tumor organoids</td>
<td align="left" colspan="1" rowspan="1">Produce heat for ablation and enable tumor visualization via their fluorescence</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Targeted ECO/siRNA nanoparticles</td>
<td align="left" colspan="1" rowspan="1">Triple Negative breast cancer (TNBC)</td>
<td align="left" colspan="1" rowspan="1">Mice and human metastasis of TNBC in 3D-organotypic</td>
<td align="left" colspan="1" rowspan="1">
<p>Possess amphiphilic characteristics that are responsive to pH levels, assisting endolysosomal escape and siRNA degradation from lysosomal activity</p>
<p>Suppress the growth of organoids from NME and MDA-MB-231 cells, as well as the epithelial-mesenchymal transition, invasion, and proliferation in NME cells</p>
</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fluorescence nanoparticles</td>
<td align="left" colspan="1" rowspan="1">Breast cancer</td>
<td align="left" colspan="1" rowspan="1">Organ-on-a-chip</td>
<td align="left" colspan="1" rowspan="1">Investigate transport mechanism, pore size effect on tumor vasculature (breast cancer), and nanoparticle penetration depth</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR96" class="usa-link" aria-describedby="CR96">96</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec19"><h2 class="pmc_sec_title">Viability of nanomedicine in clinical trials</h2>
<p id="Par34">Nanomaterials-based cancer therapies have exhibited promise in preclinical settings, yet the transition of these nanomedicine strategies to clinical practice has been limited. A mere fraction of nanomedicine strategies has made it to clinics. Challenges such as safety, efficacy, scalability, and regulatory hurdles, along with the mismatch between preclinical models and actual tumors, impede the progress of nanomaterials to clinical trials [<a href="#CR97" class="usa-link" aria-describedby="CR97">97</a>, <a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>]. Table <a href="#Tab6" class="usa-link">6</a> outlines nanomaterials-mediated drugs used in cancer therapies, including those that have been completed, discontinued, and those in phase I and II clinical trials.</p>
<section class="tw xbox font-sm" id="Tab6"><h3 class="obj_head">Table 6.</h3>
<div class="caption p"><p>Nanomaterials-based therapies for HNSCC in clinical trials</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Clinical trial number</th>
<th align="left" colspan="1" rowspan="1">Study title</th>
<th align="left" colspan="1" rowspan="1">Interventions</th>
<th align="left" colspan="1" rowspan="1">Phase of clinical study</th>
<th align="left" colspan="1" rowspan="1">Study status</th>
<th align="left" colspan="1" rowspan="1">References</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01895829" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01895829</a></td>
<td align="left" colspan="1" rowspan="1">Pilot Feasibility Study of Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI for Primary and Nodal Tumor Imaging in Locally Advanced Head and Neck Squamous Cell Carcinomas</td>
<td align="left" colspan="1" rowspan="1">
<p>Procedure: Magnetic Resonance Imaging (MRI)</p>
<p>Drug: Ferumoxytol</p>
</td>
<td align="left" colspan="1" rowspan="1">Early Phase 1</td>
<td align="left" colspan="1" rowspan="1">Terminated</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04862455" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04862455</a></td>
<td align="left" colspan="1" rowspan="1">Phase II Study of NBTXR3 Activated by Radiation and Combined with Pembrolizumab for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma With Limited PD-L1 Expression or Refractory to PD-1 Blockade</td>
<td align="left" colspan="1" rowspan="1">
<p>Other: Hafnium Oxide-containing Nanoparticles NBTXR3</p>
<p>Radiation: Hypofractionated Radiation Therapy</p>
<p>Biological: Pembrolizumab</p>
<p>Radiation: Stereotactic Body Radiation Therapy</p>
</td>
<td align="left" colspan="1" rowspan="1">Phase 2</td>
<td align="left" colspan="1" rowspan="1">Recruiting</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00851877" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00851877</a></td>
<td align="left" colspan="1" rowspan="1">A Phase I/II Study of Nab-paclitaxel, Cisplatin and Cetuximab with Concurrent Radiation Therapy for Local-regionally Advanced Head-and-neck Squamous Cell Carcinoma</td>
<td align="left" colspan="1" rowspan="1">
<p>Biological: Cetuximab</p>
<p>Drug: Cisplatin</p>
<p>Drug: Nab-Paclitaxel</p>
<p>Radiation: intensity-modulated radiation therapy</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Phase 1</p>
<p>Phase 2</p>
</td>
<td align="left" colspan="1" rowspan="1">Completed</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT00736619" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT00736619</a></td>
<td align="left" colspan="1" rowspan="1">Phase I Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients with Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC)</td>
<td align="left" colspan="1" rowspan="1">Other: Cetuximab, IMRT, Albumin-bound paclitaxel (Abraxane®)</td>
<td align="left" colspan="1" rowspan="1">Phase 1</td>
<td align="left" colspan="1" rowspan="1">Completed</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR102" class="usa-link" aria-describedby="CR102">102</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04834349" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04834349</a></td>
<td align="left" colspan="1" rowspan="1">A Phase II Study of Reirradiation with NBTXR3 in Patients with Inoperable Locoregional Recurrent Head and Neck Squamous Cell Carcinoma</td>
<td align="left" colspan="1" rowspan="1">
<p>Other: Hafnium Oxide-containing Nanoparticles NBTXR3</p>
<p>Procedure: Intensity-Modulated Proton Therapy</p>
<p>Radiation: Intensity-Modulated Radiation Therapy</p>
<p>Biological: Pembrolizumab</p>
<p>Other: Quality-of-Life Assessment</p>
<p>Other: Questionnaire Administration</p>
<p>Radiation: Stereotactic Body Radiation Therapy</p>
</td>
<td align="left" colspan="1" rowspan="1">Phase 2</td>
<td align="left" colspan="1" rowspan="1">Withdrawn</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR103" class="usa-link" aria-describedby="CR103">103</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01566435" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01566435</a></td>
<td align="left" colspan="1" rowspan="1">Phase II Trial of Nab-Paclitaxel, Cisplatin, and 5-FU (ACF) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)</td>
<td align="left" colspan="1" rowspan="1">
<p>Drug: paclitaxel albumin-stabilized nanoparticle formulation</p>
<p>Drug: Cisplatin</p>
<p>Drug: Fluorouracil</p>
<p>Radiation: Intensity modulated radiation therapy</p>
<p>Drug: Cetuximab</p>
<p>Procedure: Quality-of-life assessment</p>
</td>
<td align="left" colspan="1" rowspan="1">Phase 2</td>
<td align="left" colspan="1" rowspan="1">Completed</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04892173" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04892173</a></td>
<td align="left" colspan="1" rowspan="1">A Phase 3 Study of NBTXR3 Activated by Investigator’s Choice of Radiotherapy Alone or Radiotherapy in Combination with Cetuximab for Platinum-based Chemotherapy-Ineligible Elderly Patients With LA-HNSCC</td>
<td align="left" colspan="1" rowspan="1">
<p>Drug: NBTXR3</p>
<p>Drug: Cetuximab</p>
<p>Radiation: Radiation Therapy</p>
</td>
<td align="left" colspan="1" rowspan="1">Phase 3</td>
<td align="left" colspan="1" rowspan="1">Recruiting</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02817113" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02817113</a></td>
<td align="left" colspan="1" rowspan="1">Phase I Study of NC-6004 in Combination With 5-FU and Cetuximab as First-line Treatment in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck</td>
<td align="left" colspan="1" rowspan="1">
<p>Drug: NC-6004</p>
<p>Drug: Cetuximab</p>
<p>Drug: 5-FU</p>
</td>
<td align="left" colspan="1" rowspan="1">Phase 1</td>
<td align="left" colspan="1" rowspan="1">Terminated</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR106" class="usa-link" aria-describedby="CR106">106</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02479178" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02479178</a></td>
<td align="left" colspan="1" rowspan="1">A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients with Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck</td>
<td align="left" colspan="1" rowspan="1">Drug: BIND-014 (docetaxel nanoparticles for injectable suspension)</td>
<td align="left" colspan="1" rowspan="1">Phase 2</td>
<td align="left" colspan="1" rowspan="1">Terminated</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR107" class="usa-link" aria-describedby="CR107">107</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01847326" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01847326</a></td>
<td align="left" colspan="1" rowspan="1">Nab-Paclitaxel-based Re-induction Chemotherapy Followed by Response-stratified Chemoradiotherapy in Patients with Previously Treated Squamous Cell Carcinoma of the Head and Neck</td>
<td align="left" colspan="1" rowspan="1">
<p>Drug: carboplatin</p>
<p>Drug: paclitaxel albumin-stabilized nanoparticle formulation</p>
<p>Drug: fluorouracil</p>
<p>Drug: hydroxyurea</p>
<p>Procedure: therapeutic conventional surgery</p>
<p>Radiation: radiation therapy</p>
<p>Radiation: hyperfractionated radiation therapy</p>
<p>Other: laboratory biomarker analysis</p>
</td>
<td align="left" colspan="1" rowspan="1">Phase 1</td>
<td align="left" colspan="1" rowspan="1">Completed</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT05456022" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05456022</a></td>
<td align="left" colspan="1" rowspan="1">Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line</td>
<td align="left" colspan="1" rowspan="1">
<p>Drug: Quercetin 3,3’,4’,5,6-Pentahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one</p>
<p>Drug: Quercetin-encapsulated PLGA-PEG nanoparticles (Nano-QUT)</p>
<p>Drug: Doxorubicin chemotherapeutic drug as a positive control</p>
</td>
<td align="left" colspan="1" rowspan="1">Phase 2</td>
<td align="left" colspan="1" rowspan="1">Unknown</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03107182" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03107182</a></td>
<td align="left" colspan="1" rowspan="1">A Phase II Trial of Nivolumab/Nab-paclitaxel/Carboplatin Induction Chemotherapy Followed by Response-stratified Locoregional Therapy for Patients with Locoregionally Advanced HPV-related Oropharyngeal Cancer- the OPTIMA II Trial</td>
<td align="left" colspan="1" rowspan="1">
<p>Drug: nab-paclitaxel</p>
<p>Drug: Carboplatin</p>
<p>Drug: Nivolumab</p>
<p>Drug: Cisplatin</p>
<p>Drug: Hydroxyurea</p>
<p>Drug: 5-FU</p>
<p>Drug: Dexamethasone</p>
<p>Drug: Famotidine</p>
<p>Drug: Diphenhydramine</p>
<p>Drug: Paclitaxel</p>
<p>Procedure: Transoral robotic surgery (TORS)</p>
<p>Radiation: Adjuvant RT</p>
<p>Radiation: Chemoradiotherapy</p>
</td>
<td align="left" colspan="1" rowspan="1">Phase 2</td>
<td align="left" colspan="1" rowspan="1">Completed</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR110" class="usa-link" aria-describedby="CR110">110</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04548440" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04548440</a></td>
<td align="left" colspan="1" rowspan="1">A Phase II Clinical Study of the Efficacy and Safety of Preoperative Sintilimab in Combination with Nab-paclitaxel and Cisplatin in Borderline Resectable Esophageal Squamous Carcinoma</td>
<td align="left" colspan="1" rowspan="1">
<p>Drug: Sintilimab</p>
<p>Drug: Nab paclitaxel</p>
<p>Drug: Cisplatin</p>
</td>
<td align="left" colspan="1" rowspan="1">Phase 2</td>
<td align="left" colspan="1" rowspan="1">Completed</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT03288298" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03288298</a></td>
<td align="left" colspan="1" rowspan="1">Therapeutic Effect of Luteolin Natural Extract Versus Its Nanoparticles on Tongue Squamous Cell Carcinoma Cell Line: In Vitro Study</td>
<td align="left" colspan="1" rowspan="1">
<p>Drug: luteolin</p>
<p>Drug: nano-luteolin</p>
</td>
<td align="left" colspan="1" rowspan="1">Early Phase 1</td>
<td align="left" colspan="1" rowspan="1">Unknown</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02258659" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02258659</a></td>
<td align="left" colspan="1" rowspan="1">An Exploratory Pilot Study of Nab-paclitaxel Based Induction Chemotherapy Followed by Response-Stratified Locoregional Therapy for Patients with Stage III and IV HPV-Related Oropharyngeal Cancer—the OPTIMA HPV Trial</td>
<td align="left" colspan="1" rowspan="1">
<p>Drug: paclitaxel albumin-stabilized nanoparticle formulation</p>
<p>Drug: carboplatin</p>
<p>Radiation: radiation therapy</p>
<p>Drug: paclitaxel</p>
<p>Drug: fluorouracil</p>
<p>Drug: hydroxyurea</p>
<p>Drug: cisplatin</p>
<p>Other: laboratory biomarker analysis</p>
<p>Procedure: quality-of-life assessment</p>
</td>
<td align="left" colspan="1" rowspan="1">Phase 2</td>
<td align="left" colspan="1" rowspan="1">Completed</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR113" class="usa-link" aria-describedby="CR113">113</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT02106598" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02106598</a></td>
<td align="left" colspan="1" rowspan="1">Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases</td>
<td align="left" colspan="1" rowspan="1">Drug: fluorescent cRGDY-PEG-Cy5.5-C dots</td>
<td align="left" colspan="1" rowspan="1">
<p>Phase 1</p>
<p>Phase 2</p>
</td>
<td align="left" colspan="1" rowspan="1">Active, not recruiting</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR114" class="usa-link" aria-describedby="CR114">114</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT01735409" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT01735409</a></td>
<td align="left" colspan="1" rowspan="1">A Single Center Phase IIa Study of Nanoparticle Albumin-bound Paclitaxel in Combination with Cisplatin in Advanced Nasopharyngeal Carcinoma</td>
<td align="left" colspan="1" rowspan="1">Drug: ABX + DDP</td>
<td align="left" colspan="1" rowspan="1">
<p>Phase 1</p>
<p>Phase 2</p>
</td>
<td align="left" colspan="1" rowspan="1">Unknown</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR115" class="usa-link" aria-describedby="CR115">115</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04907422" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04907422</a></td>
<td align="left" colspan="1" rowspan="1">Gold Nanoparticles as Novel Biomarkers for Cancer Stem Cells in Salivary Gland Tumors: A Diagnostic and Prognostic Accuracy Study</td>
<td align="left" colspan="1" rowspan="1">
<p>Diagnostic Test: CD24-Gold Nanocomposite expression using Real-time quantitative polymerase chain reaction</p>
<p>Diagnostic Test: non-conjugated CD24 expression using Real-time quantitative polymerase chain reaction</p>
</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">Completed</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR116" class="usa-link" aria-describedby="CR116">116</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT04004871" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04004871</a></td>
<td align="left" colspan="1" rowspan="1">The Efficacy and Safety of Induction Chemotherapy with Nab-paclitaxel, Cisplatin and Fluorouracil, Concurrent Chemotherapy of Cisplatin and IMRT in Locoregionally Advanced Nasopharyngeal Carcinoma: A Prospective, Multi-centeric, Open, Non-controlled, Phase II Clinical Trial</td>
<td align="left" colspan="1" rowspan="1">
<p>Drug: Nab-paclitaxel, Cisplatin and Fluorouracil</p>
<p>Radiation: concurrent chemoradiotherapy</p>
</td>
<td align="left" colspan="1" rowspan="1">Phase 2</td>
<td align="left" colspan="1" rowspan="1">Unknown</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR117" class="usa-link" aria-describedby="CR117">117</a>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"><a href="https://clinicaltrials.gov/ct2/show/NCT06301165" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT06301165</a></td>
<td align="left" colspan="1" rowspan="1">TPC Versus GP Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced Nasopharyngeal Carcinoma, a Multi-center Phase II Randomized Trial</td>
<td align="left" colspan="1" rowspan="1">
<p>Drug: TPC induction chemotherapy</p>
<p>Drug: GP induction chemotherapy</p>
</td>
<td align="left" colspan="1" rowspan="1">Phase 2</td>
<td align="left" colspan="1" rowspan="1">Recruiting</td>
<td align="left" colspan="1" rowspan="1">[<a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec20"><h2 class="pmc_sec_title">Cancer treatment and nanomaterial design</h2>
<p id="Par35">Patients with HNSCC treated conventionally face a high rate of complications, necessitating the development of safer and more effective management strategies. Complications such as xerostomia, facial paralysis, mutism, and facial disfigurement significantly impact patients’ quality of life. A critical objective is to increase cure rates and extend disease-free survival, a challenge that has persisted due to late diagnoses. Functionalized gold nanomaterials offer a promising approach. These materials can home in on tumor tissues, offering molecular imaging that assists surgeons in identifying resection margins during surgery [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Additionally, they have potential in spectral cancer diagnostics [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. With their high sensitivity to OSCC, these nanomaterials could facilitate earlier diagnosis and more accurate staging. The author posits that the incorporation of functionalized gold nanomaterials into clinical practice could greatly benefit early diagnosis, prevention, and surgical intervention. They are deemed suitable for clinical trials and subsequent research in HNSCC management.</p>
<p id="Par36">HNSCC, being accessible and palpable, offers an advantageous aspect for treatment via PDT, which the author deems to have substantial application potential. PDT preserves the oral cavity’s structure, function, and aesthetics while minimizing adverse effects [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>]. A specific biomimetic nanomaterial, PCN-CQ@CCM [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>], coated with a membrane from oral squamous cell carcinoma cells, is believed to augment PDT’s effectiveness. This enhancement is achieved by introducing a targeted therapeutic approach and inhibiting autophagy, a cellular self-digestion process that can counteract the therapy’s objectives. The author posits that this nanomaterial-based treatment could protect the tumor’s surrounding healthy tissues and organs, thus preventing the oral cancer’s impact on the oral and jaw systems. Considering a clinical trial for such nanomaterials in HNSCC is advocated, with the anticipation that it may ameliorate or resolve clinical challenges and pave the way for future investigative endeavors.</p>
<p id="Par37">Nanotechnology offers unique advantages, such as the ability to load multiple substances into a single carrier and to combine diagnostic and therapeutic functions. This allows for the development of nanoparticles that encapsulate both therapeutic drugs and imaging contrast agents, thus improving diagnostic imaging and therapeutic effectiveness. Jing et al. have crafted a nanoprobe derived from extracellular vesicles, which exhibit a strong affinity for binding to tumor cells. When integrated with PET, CT, and near-infrared fluorescence (NIRF) imaging, this nanoprobe offers clear visualization of colon cancer in its natural environment, supporting surgical navigation. The use of real-time NIRF imaging is especially adept at identifying the precise boundaries of tumors during surgical procedures in mice [<a href="#CR119" class="usa-link" aria-describedby="CR119">119</a>].</p>
<p id="Par38">Diagnostic imaging can be effectively integrated with phototherapy to enhance cancer treatment. Zhang et al. created an amphiphilic Janus nanoparticle (JNP) from PCL-AuNC/Fe(OH)<sub>3</sub>-PAA for the dual delivery of hydrophilic drugs like doxorubicin (DOX) and hydrophobic drugs like docetaxel. These JNPs feature pH sensitivity and respond to near-infrared light, facilitating the timed release of their drug payloads. The integration of AuNC and Fe(OH)<sub>3</sub> nanomaterials provides the system with capabilities for CT/MR imaging. When activated by a near-infrared laser, these materials can initiate a chemophotothermal therapeutic approach, which has been shown to significantly inhibit tumor growth [<a href="#CR120" class="usa-link" aria-describedby="CR120">120</a>]. Qiu et al. introduced a composite drug delivery system named ATO/PFH NPs@Au-cRGD, which also serves as a nano ultrasound contrast agent. This system is engineered to combine the benefits of ultrasound imaging with immune stimulation. The synergistic effect is achieved through the use of iron deposition and PTT [<a href="#CR121" class="usa-link" aria-describedby="CR121">121</a>].</p>
<p id="Par39">Currently, nanomaterial-based strategies for integrated diagnosis and treatment have shown a strong focus on cancers of the digestive system. In contrast, research on HNSCC is markedly lacking. This discrepancy indicates a clear research gap that necessitates additional investigation. Gold nanomaterials have become a pivotal focus in nanotechnology, particularly for their applications in medicine. They are already in use for diagnostics [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>] and therapy [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. The evolving research is poised to develop these materials to a point where they can integrate diagnosis with treatment, potentially expanding their medical applications. Gold nanomaterials boast unique properties—biocompatibility, modifiable surfaces, and robust optical absorption—that render them ideal for a spectrum of uses in biomedicine. They serve not only as imaging agents and drug carriers but also in photothermal therapies and molecular targeting. The continuous pursuit of innovation in this field is expected to yield multifunctional gold nanomaterials. These advanced materials are set to provide tailored and efficacious treatments, thereby improving patient outcomes. The convergence of diagnostic and therapeutic capabilities into one platform is anticipated to enable real-time treatment monitoring and dosage personalization. Such an integration could be transformative for cancer treatment and other medical interventions.</p></section><section id="Sec21"><h2 class="pmc_sec_title">Discussion and perspectives</h2>
<p id="Par40">Nanomaterials have great application and development potential in the future. Yet, their entry into the body’s internal circulation systems necessitates a critical evaluation of biosafety. The potential toxicity of these materials is influenced by factors such as particle size, shape, surface charge, stability, and concentration. When formulating nanomaterials for cancer therapies, it is crucial to fine-tune their physical and chemical properties to minimize harm to healthy cells. Moreover, studies have indicated that nanomaterials might induce DNA damage and alter gene methylation patterns, which could potentially initiate carcinogenesis [<a href="#CR122" class="usa-link" aria-describedby="CR122">122</a>, <a href="#CR123" class="usa-link" aria-describedby="CR123">123</a>]. Despite these findings, there is no conclusive evidence that nanomaterials can directly trigger malignant transformations or genetic mutations in cells. The absence of direct evidence, however, does not equate to safety. The long-term effects of nanomaterial metabolism and accumulation within the body remain uncertain and warrant further investigation through extended exposure studies.</p>
<p id="Par41">The translation of nanomaterials into clinical practice poses significant challenges, particularly regarding their ability to address clinical needs and support widespread use. A primary obstacle to clinical application is cost. The expense of nanomaterial formulations is a limiting factor. However, this cost can be mitigated by using less material and employing strategies that enhance therapeutic efficacy. Firstly, the incorporation of cost-effective adjuvants or the development of composite nanomaterials can enhance treatment outcomes [<a href="#CR124" class="usa-link" aria-describedby="CR124">124</a>]. Secondly, advanced drug delivery methods, such as microneedles for precise delivery, layered self-assembly of nanomaterials, and nanoscale systems for controlled drug release [<a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>], can be implemented to optimize treatment and reduce the overall dosage of nanomaterials required. Furthermore, refining the formulation and refining the manufacturing process are effective strategies for lowering production expenses. Given the diversity of nanomaterials and their properties, a multifaceted approach to their application in HNSCC is essential. Future research should delve deeper into innovative mechanisms of action to refine therapies and minimize adverse effects.</p></section><section id="Sec22"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par42">Currently, nanomaterial research is in its early stages, yet it is gaining increasing attention, particularly in the areas of cancer treatment and drug design. These materials possess unique characteristics, such as surface effects, quantum size effects, and macroscopic quantum tunneling effects, coupled with remarkable thermal, biological, and electromagnetic properties [<a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>–<a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>]. These attributes distinguish nanomaterials from traditional materials. In cancer research, the utilization of nanomaterials is on the rise [<a href="#CR130" class="usa-link" aria-describedby="CR130">130</a>–<a href="#CR133" class="usa-link" aria-describedby="CR133">133</a>]. Metal and metal oxide nanoparticles, among others, have shown distinctive anti-tumor capabilities, highlighting the significant potential of nanomaterials in oncology [<a href="#CR134" class="usa-link" aria-describedby="CR134">134</a>–<a href="#CR136" class="usa-link" aria-describedby="CR136">136</a>].</p>
<p id="Par43">However, it is crucial to consider the potential toxicity of innovative nanomaterials. Even with the EPR effect, nanomaterials have the potential to distribute and accumulate in different organs. Specifically, metal-based nanomaterials can produce ROS, which may compromise cell membrane integrity and lead to epigenetic changes [<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>, <a href="#CR138" class="usa-link" aria-describedby="CR138">138</a>]. Furthermore, the effectiveness and safety of nanomaterials are determined by a variety of factors. These include the size [<a href="#CR139" class="usa-link" aria-describedby="CR139">139</a>], shape [<a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>], surface characteristics [<a href="#CR141" class="usa-link" aria-describedby="CR141">141</a>], crystalline structure [<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>], tendency to aggregate [<a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>], and solubility [<a href="#CR144" class="usa-link" aria-describedby="CR144">144</a>] of the particles. Addressing the toxicity of nanomaterials is a critical step in ensuring their successful transition to clinical use.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Credit Author Statement Guo Cheng：Conceptualization, Writing—Original Draft, Writing—Review &amp; Editing, Visualization. Wentao Li：Writing—Review &amp; Editing. Xin Zhu：Project administration. Chenping Zhang：Supervision, Project administration, Funding acquisition.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>The authors declare that no external funding was received for this study. All research activities were supported by the authors’ institutions or personal resources.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par44">No animal or human studies were carried out by the authors for this article.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par45">All authors have approved the content of the manuscript prior to its submission for publication.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par46">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Xin Zhu, Email: zhuxin@zjcc.org.cn.</p>
<p>Chenping Zhang, Email: zhangcp@zjcc.org.cn.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
</cite> [<a href="https://doi.org/10.3322/caac.21492" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30207593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bray%20F,%20Ferlay%20J,%20Soerjomataram%20I,%20Siegel%20RL,%20Torre%20LA,%20Jemal%20A.%20Global%20cancer%20statistics%202018:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries.%20CA%20Cancer%20J%20Clin.%202018;68:394%E2%80%93424." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941–53.
</cite> [<a href="https://doi.org/10.1002/ijc.31937" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30350310/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferlay%20J,%20Colombet%20M,%20Soerjomataram%20I,%20Mathers%20C,%20Parkin%20DM,%20Pi%C3%B1eros%20M,%20Znaor%20A,%20Bray%20F.%20Estimating%20the%20global%20cancer%20incidence%20and%20mortality%20in%202018:%20GLOBOCAN%20sources%20and%20methods.%20Int%20J%20Cancer.%202019;144:1941%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Xue Y, Jiang X, Wang J, Zong Y, Yuan Z, Miao S, Mao X. Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma. Biomark Res. 2023;11: 2.
</cite> [<a href="https://doi.org/10.1186/s40364-022-00433-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9814270/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36600313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xue%20Y,%20Jiang%20X,%20Wang%20J,%20Zong%20Y,%20Yuan%20Z,%20Miao%20S,%20Mao%20X.%20Effect%20of%20regulatory%20cell%20death%20on%20the%20occurrence%20and%20development%20of%20head%20and%20neck%20squamous%20cell%20carcinoma.%20Biomark%20Res.%202023;11:%202." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Carbone M, Amelio I, Affar EB, Brugarolas J, Cannon-Albright LA, Cantley LC, Cavenee WK, Chen Z, Croce CM, Andrea A, et al. Consensus report of the 8 and 9th Weinman symposia on gene x environment interaction in carcinogenesis: novel opportunities for precision medicine. Cell Death Differ. 2018;25:1885–904.
</cite> [<a href="https://doi.org/10.1038/s41418-018-0213-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6219489/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30323273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Carbone%20M,%20Amelio%20I,%20Affar%20EB,%20Brugarolas%20J,%20Cannon-Albright%20LA,%20Cantley%20LC,%20Cavenee%20WK,%20Chen%20Z,%20Croce%20CM,%20Andrea%20A,%20et%20al.%20Consensus%20report%20of%20the%208%20and%209th%20Weinman%20symposia%20on%20gene%20x%20environment%20interaction%20in%20carcinogenesis:%20novel%20opportunities%20for%20precision%20medicine.%20Cell%20Death%20Differ.%202018;25:1885%E2%80%93904." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Geng X, Zhang Y, Zeng Z, Zhu Z, Wang H, Yu W, Li Q. Molecular characteristics, prognostic value, and immune characteristics of m(6)A regulators identified in head and neck squamous cell carcinoma. Front Oncol. 2021;11: 629718.
</cite> [<a href="https://doi.org/10.3389/fonc.2021.629718" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8014089/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33816266/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Geng%20X,%20Zhang%20Y,%20Zeng%20Z,%20Zhu%20Z,%20Wang%20H,%20Yu%20W,%20Li%20Q.%20Molecular%20characteristics,%20prognostic%20value,%20and%20immune%20characteristics%20of%20m(6)A%20regulators%20identified%20in%20head%20and%20neck%20squamous%20cell%20carcinoma.%20Front%20Oncol.%202021;11:%20629718." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Cao M, Shi E, Wang H, Mao L, Wu Q, Li X, Liang Y, Yang X, Wang Y, Li C. Personalized targeted therapeutic strategies against oral squamous cell carcinoma. an evidence-based review of literature. Int J Nanomedicine. 2022;17:4293–306.
</cite> [<a href="https://doi.org/10.2147/IJN.S377816" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9484769/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36134201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cao%20M,%20Shi%20E,%20Wang%20H,%20Mao%20L,%20Wu%20Q,%20Li%20X,%20Liang%20Y,%20Yang%20X,%20Wang%20Y,%20Li%20C.%20Personalized%20targeted%20therapeutic%20strategies%20against%20oral%20squamous%20cell%20carcinoma.%20an%20evidence-based%20review%20of%20literature.%20Int%20J%20Nanomedicine.%202022;17:4293%E2%80%93306." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020;6:92.
</cite> [<a href="https://doi.org/10.1038/s41572-020-00224-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7944998/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33243986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Johnson%20DE,%20Burtness%20B,%20Leemans%20CR,%20Lui%20VWY,%20Bauman%20JE,%20Grandis%20JR.%20Head%20and%20neck%20squamous%20cell%20carcinoma.%20Nat%20Rev%20Dis%20Primers.%202020;6:92." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008;371:1695–709.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(08)60728-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7720415/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18486742/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Argiris%20A,%20Karamouzis%20MV,%20Raben%20D,%20Ferris%20RL.%20Head%20and%20neck%20cancer.%20Lancet.%202008;371:1695%E2%80%93709." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Andrade LM, Costa GMJ. Insights into gold nanoparticles possibilities for diagnosis and treatment of the head and neck upper aerodigestive tract cancers. Cancers (Basel). 2023. 10.3390/cancers15072080.
</cite> [<a href="https://doi.org/10.3390/cancers15072080" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10093449/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37046740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andrade%20LM,%20Costa%20GMJ.%20Insights%20into%20gold%20nanoparticles%20possibilities%20for%20diagnosis%20and%20treatment%20of%20the%20head%20and%20neck%20upper%20aerodigestive%20tract%20cancers.%20Cancers%20(Basel).%202023.%2010.3390/cancers15072080." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Cheng Z, Li M, Dey R, Chen Y. Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol. 2021;14:85.
</cite> [<a href="https://doi.org/10.1186/s13045-021-01096-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8165984/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34059100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng%20Z,%20Li%20M,%20Dey%20R,%20Chen%20Y.%20Nanomaterials%20for%20cancer%20therapy:%20current%20progress%20and%20perspectives.%20J%20Hematol%20Oncol.%202021;14:85." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Cejas P, Casado E, Belda-Iniesta C, De Castro J, Espinosa E, Redondo A, Sereno M, García-Cabezas MA, Vara JA, Domínguez-Cáceres A, et al. Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes Control. 2004;15:707–19.
</cite> [<a href="https://doi.org/10.1023/B:CACO.0000036189.61607.52" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15280629/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cejas%20P,%20Casado%20E,%20Belda-Iniesta%20C,%20De%20Castro%20J,%20Espinosa%20E,%20Redondo%20A,%20Sereno%20M,%20Garc%C3%ADa-Cabezas%20MA,%20Vara%20JA,%20Dom%C3%ADnguez-C%C3%A1ceres%20A,%20et%20al.%20Implications%20of%20oxidative%20stress%20and%20cell%20membrane%20lipid%20peroxidation%20in%20human%20cancer%20(Spain).%20Cancer%20Causes%20Control.%202004;15:707%E2%80%9319." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Chow LQM. Head and neck cancer. N Engl J Med. 2020;382:60–72.
</cite> [<a href="https://doi.org/10.1056/NEJMra1715715" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31893516/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chow%20LQM.%20Head%20and%20neck%20cancer.%20N%20Engl%20J%20Med.%202020;382:60%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Miller ZA, Muthuswami S, Mueller A, Ma RZ, Sywanycz SM, Naik A, Huang L, Brody RM, Diab A, Carey RM, Lee RJ. GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer eff ects of bitter receptor agonists in head and neck squamous carcinoma c ells. Cell Death Discov. 2024;10: 339.
</cite> [<a href="https://doi.org/10.1038/s41420-024-02106-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11282258/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39060287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miller%20ZA,%20Muthuswami%20S,%20Mueller%20A,%20Ma%20RZ,%20Sywanycz%20SM,%20Naik%20A,%20Huang%20L,%20Brody%20RM,%20Diab%20A,%20Carey%20RM,%20Lee%20RJ.%20GLUT1%20inhibitor%20BAY-876%20induces%20apoptosis%20and%20enhances%20anti-cancer%20eff%20ects%20of%20bitter%20receptor%20agonists%20in%20head%20and%20neck%20squamous%20carcinoma%20c%20ells.%20Cell%20Death%20Discov.%202024;10:%20339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Restaino AC, Walz A, Barclay SM, Fettig RR, Vermeer PD. Tumor-associated genetic amplifications impact extracellular vesicle m iRNA cargo and their recruitment of nerves in head and neck cancer. FASEB J. 2024;38: e23803.
</cite> [<a href="https://doi.org/10.1096/fj.202400625RR" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11262563/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38963404/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Restaino%20AC,%20Walz%20A,%20Barclay%20SM,%20Fettig%20RR,%20Vermeer%20PD.%20Tumor-associated%20genetic%20amplifications%20impact%20extracellular%20vesicle%20m%20iRNA%20cargo%20and%20their%20recruitment%20of%20nerves%20in%20head%20and%20neck%20cancer.%20FASEB%20J.%202024;38:%20e23803." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576–82.
</cite> [<a href="https://doi.org/10.1038/nature14129" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4311405/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25631445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cancer%20Genome%20Atlas%20Network.%20Comprehensive%20genomic%20characterization%20of%20head%20and%20neck%20squamous%20cell%20carcinomas.%20Nature.%202015;517:576%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Wang Z, Valera JC, Zhao X, Chen Q, Gutkind JS. Mtor co-targeting strategies for head and neck cancer therapy. Cancer Metastasis Rev. 2017;36:491–502.
</cite> [<a href="https://doi.org/10.1007/s10555-017-9688-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5613059/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28822012/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Z,%20Valera%20JC,%20Zhao%20X,%20Chen%20Q,%20Gutkind%20JS.%20Mtor%20co-targeting%20strategies%20for%20head%20and%20neck%20cancer%20therapy.%20Cancer%20Metastasis%20Rev.%202017;36:491%E2%80%93502." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Geiger JL, Grandis JR, Bauman JE. The STAT3 pathway as a therapeutic target in head and neck cancer: barriers and innovations. Oral Oncol. 2016;56:84–92.
</cite> [<a href="https://doi.org/10.1016/j.oraloncology.2015.11.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5590227/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26733183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Geiger%20JL,%20Grandis%20JR,%20Bauman%20JE.%20The%20STAT3%20pathway%20as%20a%20therapeutic%20target%20in%20head%20and%20neck%20cancer:%20barriers%20and%20innovations.%20Oral%20Oncol.%202016;56:84%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Johnson DE, O’Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15:234–48.
</cite> [<a href="https://doi.org/10.1038/nrclinonc.2018.8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5858971/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29405201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Johnson%20DE,%20O%E2%80%99Keefe%20RA,%20Grandis%20JR.%20Targeting%20the%20IL-6/JAK/STAT3%20signalling%20axis%20in%20cancer.%20Nat%20Rev%20Clin%20Oncol.%202018;15:234%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Chakraborty B, Mukhopadhyay D, Roychowdhury A, Basu M, Alam N, Chatterjee K, Chakrabarti J, Panda CK. Differential Wnt-β- catenin pathway activation in HPV positive and neg ative oral epithelium is transmitted during head and neck tumorigenesi s: clinical implications. Med Microbiol Immunol. 2021;210:49–63.
</cite> [<a href="https://doi.org/10.1007/s00430-020-00697-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33226516/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chakraborty%20B,%20Mukhopadhyay%20D,%20Roychowdhury%20A,%20Basu%20M,%20Alam%20N,%20Chatterjee%20K,%20Chakrabarti%20J,%20Panda%20CK.%20Differential%20Wnt-%CE%B2-%20catenin%20pathway%20activation%20in%20HPV%20positive%20and%20neg%20ative%20oral%20epithelium%20is%20transmitted%20during%20head%20and%20neck%20tumorigenesi%20s:%20clinical%20implications.%20Med%20Microbiol%20Immunol.%202021;210:49%E2%80%9363." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>European Commission. Commission recommendation of 18 October 2011 on the definition of nanomaterial. Off J Eur Union. 2011;275:38.</cite> [<a href="https://scholar.google.com/scholar_lookup?European%20Commission.%20Commission%20recommendation%20of%2018%20October%202011%20on%20the%20definition%20of%20nanomaterial.%20Off%20J%20Eur%20Union.%202011;275:38." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Ferreira-Faria I, Yousefiasl S, Macário-Soares A, Pereira-Silva M, Peixoto D, Zafar H, Raza F, Faneca H, Veiga F, Hamblin MR, et al. Stem cell membrane-coated abiotic nanomaterials for biomedical applications. J Control Release. 2022;351:174–97.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2022.09.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36103910/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferreira-Faria%20I,%20Yousefiasl%20S,%20Mac%C3%A1rio-Soares%20A,%20Pereira-Silva%20M,%20Peixoto%20D,%20Zafar%20H,%20Raza%20F,%20Faneca%20H,%20Veiga%20F,%20Hamblin%20MR,%20et%20al.%20Stem%20cell%20membrane-coated%20abiotic%20nanomaterials%20for%20biomedical%20applications.%20J%20Control%20Release.%202022;351:174%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Zare M, Pemmada R, Madhavan M, Shailaja A, Ramakrishna S, Kandiyil SP, Donahue JM, Thomas V. Encapsulation of miRNA and siRNA into nanomaterials for cancer therapeutics. Pharmaceutics. 2022;14(8):1620.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics14081620" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9416290/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36015246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zare%20M,%20Pemmada%20R,%20Madhavan%20M,%20Shailaja%20A,%20Ramakrishna%20S,%20Kandiyil%20SP,%20Donahue%20JM,%20Thomas%20V.%20Encapsulation%20of%20miRNA%20and%20siRNA%20into%20nanomaterials%20for%20cancer%20therapeutics.%20Pharmaceutics.%202022;14(8):1620." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Baig N, Kammakakam I, Falath W. Nanomaterials: a review of synthesis methods, properties, recent progress, and challenges. Mater Adv. 2021;2:1821–71.</cite> [<a href="https://scholar.google.com/scholar_lookup?Baig%20N,%20Kammakakam%20I,%20Falath%20W.%20Nanomaterials:%20a%20review%20of%20synthesis%20methods,%20properties,%20recent%20progress,%20and%20challenges.%20Mater%20Adv.%202021;2:1821%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Kagdada HL, Bhojani AK, Singh DK. An overview of nanomaterials: history, fundamentals, and applications. In: Singh DK, Singh S, Singh P, editors. Nanomaterials: Advances and Applications. Singapore: Springer; 2023. p. 1–26.</cite> [<a href="https://scholar.google.com/scholar_lookup?Kagdada%20HL,%20Bhojani%20AK,%20Singh%20DK.%20An%20overview%20of%20nanomaterials:%20history,%20fundamentals,%20and%20applications.%20In:%20Singh%20DK,%20Singh%20S,%20Singh%20P,%20editors.%20Nanomaterials:%20Advances%20and%20Applications.%20Singapore:%20Springer;%202023.%20p.%201%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Dai ZR, Bradley JP, Joswiak DJ, Brownlee DE, Hill HG, Genge MJ. Possible in situ formation of meteoritic nanodiamonds in the early solar system. Nature. 2002;418:157–9.
</cite> [<a href="https://doi.org/10.1038/nature00897" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12110882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dai%20ZR,%20Bradley%20JP,%20Joswiak%20DJ,%20Brownlee%20DE,%20Hill%20HG,%20Genge%20MJ.%20Possible%20in%20situ%20formation%20of%20meteoritic%20nanodiamonds%20in%20the%20early%20solar%20system.%20Nature.%202002;418:157%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Keten S, Buehler MJ. Atomistic model of the spider silk nanostructure. Appl Phys Lett. 2010. 10.1063/1.3385388.</cite> [<a href="https://scholar.google.com/scholar_lookup?Keten%20S,%20Buehler%20MJ.%20Atomistic%20model%20of%20the%20spider%20silk%20nanostructure.%20Appl%20Phys%20Lett.%202010.%2010.1063/1.3385388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Reibold M, Pätzke N, Levin AA, Kochmann W, Shakhverdova IP, Paufler P, Meyer DC. Structure of several historic blades at nanoscale. Cryst Res Technol. 2009;44:1139–46.</cite> [<a href="https://scholar.google.com/scholar_lookup?Reibold%20M,%20P%C3%A4tzke%20N,%20Levin%20AA,%20Kochmann%20W,%20Shakhverdova%20IP,%20Paufler%20P,%20Meyer%20DC.%20Structure%20of%20several%20historic%20blades%20at%20nanoscale.%20Cryst%20Res%20Technol.%202009;44:1139%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Iijima S. Helical microtubules of graphitic carbon. Nature. 1991;354:56–8.</cite> [<a href="https://scholar.google.com/scholar_lookup?Iijima%20S.%20Helical%20microtubules%20of%20graphitic%20carbon.%20Nature.%201991;354:56%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Kroto HW, Heath JR, O’Brien SC, Curl RF, Smalley RE. C60: buckminsterfullerene. Nature. 1985;318:162–3.</cite> [<a href="https://scholar.google.com/scholar_lookup?Kroto%20HW,%20Heath%20JR,%20O%E2%80%99Brien%20SC,%20Curl%20RF,%20Smalley%20RE.%20C60:%20buckminsterfullerene.%20Nature.%201985;318:162%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Xu X, Ray R, Gu Y, Ploehn HJ, Gearheart L, Raker K, Scrivens WA. Electrophoretic analysis and purification of fluorescent single-walled carbon nanotube fragments. J Am Chem Soc. 2004;126:12736–7.
</cite> [<a href="https://doi.org/10.1021/ja040082h" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15469243/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20X,%20Ray%20R,%20Gu%20Y,%20Ploehn%20HJ,%20Gearheart%20L,%20Raker%20K,%20Scrivens%20WA.%20Electrophoretic%20analysis%20and%20purification%20of%20fluorescent%20single-walled%20carbon%20nanotube%20fragments.%20J%20Am%20Chem%20Soc.%202004;126:12736%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Yang G, Li L, Lee WB, Ng MC. Structure of graphene and its disorders: a review. Sci Technol Adv Mater. 2018;19:613–48.
</cite> [<a href="https://doi.org/10.1080/14686996.2018.1494493" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6116708/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30181789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20G,%20Li%20L,%20Lee%20WB,%20Ng%20MC.%20Structure%20of%20graphene%20and%20its%20disorders:%20a%20review.%20Sci%20Technol%20Adv%20Mater.%202018;19:613%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Wang J, Fan HC, Behr B, Quake SR. Genome-wide single-cell analysis of recombination activity and <em>de novo</em> mutation rates in human sperm. Cell. 2012;150:402–12.
</cite> [<a href="https://doi.org/10.1016/j.cell.2012.06.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3525523/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22817899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20J,%20Fan%20HC,%20Behr%20B,%20Quake%20SR.%20Genome-wide%20single-cell%20analysis%20of%20recombination%20activity%20and%20de%20novo%20mutation%20rates%20in%20human%20sperm.%20Cell.%202012;150:402%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Meinel L, Betz O, Fajardo R, Hofmann S, Nazarian A, Cory E, Hilbe M, McCool J, Langer R, Vunjak-Novakovic G, et al. Silk based biomaterials to heal critical sized femur defects. Bone. 2006;39:922–31.
</cite> [<a href="https://doi.org/10.1016/j.bone.2006.04.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16757219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meinel%20L,%20Betz%20O,%20Fajardo%20R,%20Hofmann%20S,%20Nazarian%20A,%20Cory%20E,%20Hilbe%20M,%20McCool%20J,%20Langer%20R,%20Vunjak-Novakovic%20G,%20et%20al.%20Silk%20based%20biomaterials%20to%20heal%20critical%20sized%20femur%20defects.%20Bone.%202006;39:922%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Liu H, Slamovich EB, Webster TJ. Less harmful acidic degradation of poly(lacticco-glycolic acid) bone tissue engineering scaffolds through titania nanoparticle addition. Int J Nanomed. 2006;1:541–5.</cite> [<a href="https://doi.org/10.2147/nano.2006.1.4.541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2676635/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17722285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20H,%20Slamovich%20EB,%20Webster%20TJ.%20Less%20harmful%20acidic%20degradation%20of%20poly(lacticco-glycolic%20acid)%20bone%20tissue%20engineering%20scaffolds%20through%20titania%20nanoparticle%20addition.%20Int%20J%20Nanomed.%202006;1:541%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Bharali DJ, Khalil M, Gurbuz M, Simone TM, Mousa SA. Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. Int J Nanomed. 2009;4:1–7.</cite> [<a href="/articles/PMC2720735/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19421366/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bharali%20DJ,%20Khalil%20M,%20Gurbuz%20M,%20Simone%20TM,%20Mousa%20SA.%20Nanoparticles%20and%20cancer%20therapy:%20a%20concise%20review%20with%20emphasis%20on%20dendrimers.%20Int%20J%20Nanomed.%202009;4:1%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Abed N, Couvreur P. Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. Int J Antimicrob Agents. 2014;43:485–96.
</cite> [<a href="https://doi.org/10.1016/j.ijantimicag.2014.02.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24721232/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abed%20N,%20Couvreur%20P.%20Nanocarriers%20for%20antibiotics:%20a%20promising%20solution%20to%20treat%20intracellular%20bacterial%20infections.%20Int%20J%20Antimicrob%20Agents.%202014;43:485%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Putta S, Sharma RK, Khandelwal P. Metal nanoparticles: synthesis, characterization, and biomedical applications. Berlin Heidelberg: Springer Nature Singapore; 2023.</cite> [<a href="https://scholar.google.com/scholar_lookup?Putta%20S,%20Sharma%20RK,%20Khandelwal%20P.%20Metal%20nanoparticles:%20synthesis,%20characterization,%20and%20biomedical%20applications.%20Berlin%20Heidelberg:%20Springer%20Nature%20Singapore;%202023." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Rodraiguez JA, Fernaandez-Garcaia M. Synthesis, properties, and applications of oxide nanomaterials. Hoboken: John Wiley &amp; Sons; 2007.</cite> [<a href="https://scholar.google.com/scholar_lookup?Rodraiguez%20JA,%20Fernaandez-Garcaia%20M.%20Synthesis,%20properties,%20and%20applications%20of%20oxide%20nanomaterials.%20Hoboken:%20John%20Wiley%20&amp;%20Sons;%202007." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Fernández-García M, Martínez-Arias A, Hanson JC, Rodriguez JA. Nanostructured oxides in chemistry: characterization and properties. Chem Rev. 2004;104:4063–104.
</cite> [<a href="https://doi.org/10.1021/cr030032f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15352786/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fern%C3%A1ndez-Garc%C3%ADa%20M,%20Mart%C3%ADnez-Arias%20A,%20Hanson%20JC,%20Rodriguez%20JA.%20Nanostructured%20oxides%20in%20chemistry:%20characterization%20and%20properties.%20Chem%20Rev.%202004;104:4063%E2%80%93104." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Singh P, Pandit S, Mokkapati V, Garg A, Ravikumar V, Mijakovic I. Gold nanoparticles in diagnostics and therapeutics for human cancer. Int J Mol Sci. 2018;19(7):1979.
</cite> [<a href="https://doi.org/10.3390/ijms19071979" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6073740/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29986450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Singh%20P,%20Pandit%20S,%20Mokkapati%20V,%20Garg%20A,%20Ravikumar%20V,%20Mijakovic%20I.%20Gold%20nanoparticles%20in%20diagnostics%20and%20therapeutics%20for%20human%20cancer.%20Int%20J%20Mol%20Sci.%202018;19(7):1979." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Cui D, Zhao D, Wang B, Liu B, Yang L, Xie H, Wang Z, Cheng L, Qiu X, Ma Z, et al. Safflower (<em>Carthamus tinctorius</em> L.) polysaccharide attenuates cellular apoptosis in steroid-induced avascular necrosis of femoral head by targeting caspase-3-dependent signaling pathway. Int J Biol Macromol. 2018;116:106–12.
</cite> [<a href="https://doi.org/10.1016/j.ijbiomac.2018.04.181" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29729342/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cui%20D,%20Zhao%20D,%20Wang%20B,%20Liu%20B,%20Yang%20L,%20Xie%20H,%20Wang%20Z,%20Cheng%20L,%20Qiu%20X,%20Ma%20Z,%20et%20al.%20Safflower%20(Carthamus%20tinctorius%20L.)%20polysaccharide%20attenuates%20cellular%20apoptosis%20in%20steroid-induced%20avascular%20necrosis%20of%20femoral%20head%20by%20targeting%20caspase-3-dependent%20signaling%20pathway.%20Int%20J%20Biol%20Macromol.%202018;116:106%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Xue L, Yan B, Li Y, Tan Y, Luo X, Wang M. Surface-enhanced raman spectroscopy of blood serum based on gold nanoparticles for tumor stages detection and histologic grades classification of oral squamous cell carcinoma. Int J Nanomed. 2018;13:4977–86.</cite> [<a href="https://doi.org/10.2147/IJN.S167996" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6124473/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30214201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xue%20L,%20Yan%20B,%20Li%20Y,%20Tan%20Y,%20Luo%20X,%20Wang%20M.%20Surface-enhanced%20raman%20spectroscopy%20of%20blood%20serum%20based%20on%20gold%20nanoparticles%20for%20tumor%20stages%20detection%20and%20histologic%20grades%20classification%20of%20oral%20squamous%20cell%20carcinoma.%20Int%20J%20Nanomed.%202018;13:4977%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Major JL, Meade TJ. Bioresponsive, cell-penetrating, and multimeric MR contrast agents. Acc Chem Res. 2009;42:893–903.
</cite> [<a href="https://doi.org/10.1021/ar800245h" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2739617/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19537782/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Major%20JL,%20Meade%20TJ.%20Bioresponsive,%20cell-penetrating,%20and%20multimeric%20MR%20contrast%20agents.%20Acc%20Chem%20Res.%202009;42:893%E2%80%93903." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Li H, Luo D, Yuan C, Wang X, Wang J, Basilion JP, Meade TJ. Magnetic resonance imaging of PSMA-positive prostate cancer by a targeted and activatable Gd(III) MR contrast agent. J Am Chem Soc. 2021;143:17097–108.
</cite> [<a href="https://doi.org/10.1021/jacs.1c07377" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34612645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20H,%20Luo%20D,%20Yuan%20C,%20Wang%20X,%20Wang%20J,%20Basilion%20JP,%20Meade%20TJ.%20Magnetic%20resonance%20imaging%20of%20PSMA-positive%20prostate%20cancer%20by%20a%20targeted%20and%20activatable%20Gd(III)%20MR%20contrast%20agent.%20J%20Am%20Chem%20Soc.%202021;143:17097%E2%80%93108." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Zheng C, Wang Z, Xu H, Huang H, Tao X, Hu Y, He Y, Zhang Z, Huang X. Redox-activatable magnetic nanoarchitectonics for self-enhanced tumor imaging and synergistic photothermal-chemodynamic therapy. Small Methods. 2024;8: e2301099.
</cite> [<a href="https://doi.org/10.1002/smtd.202301099" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37890280/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20C,%20Wang%20Z,%20Xu%20H,%20Huang%20H,%20Tao%20X,%20Hu%20Y,%20He%20Y,%20Zhang%20Z,%20Huang%20X.%20Redox-activatable%20magnetic%20nanoarchitectonics%20for%20self-enhanced%20tumor%20imaging%20and%20synergistic%20photothermal-chemodynamic%20therapy.%20Small%20Methods.%202024;8:%20e2301099." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Zheng Y, Liang W, Yuan Y, Xiong C, Xie S, Wang H, Chai Y, Yuan R. Wavelength-resolved simultaneous photoelectrochemical bifunctional sensor on single interface: a newly in vitro approach for multiplexed DNA monitoring in cancer cells. Biosens Bioelectron. 2016;81:423–30.
</cite> [<a href="https://doi.org/10.1016/j.bios.2016.03.032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27003607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng%20Y,%20Liang%20W,%20Yuan%20Y,%20Xiong%20C,%20Xie%20S,%20Wang%20H,%20Chai%20Y,%20Yuan%20R.%20Wavelength-resolved%20simultaneous%20photoelectrochemical%20bifunctional%20sensor%20on%20single%20interface:%20a%20newly%20in%20vitro%20approach%20for%20multiplexed%20DNA%20monitoring%20in%20cancer%20cells.%20Biosens%20Bioelectron.%202016;81:423%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Zhang Y, Chen R, Xu L, Ning Y, Xie S, Zhang GJ. Silicon nanowire biosensor for highly sensitive and multiplexed detection of oral squamous cell carcinoma biomarkers in saliva. Anal Sci. 2015;31:73–8.
</cite> [<a href="https://doi.org/10.2116/analsci.31.73" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25746803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Y,%20Chen%20R,%20Xu%20L,%20Ning%20Y,%20Xie%20S,%20Zhang%20GJ.%20Silicon%20nanowire%20biosensor%20for%20highly%20sensitive%20and%20multiplexed%20detection%20of%20oral%20squamous%20cell%20carcinoma%20biomarkers%20in%20saliva.%20Anal%20Sci.%202015;31:73%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Jimenez Jimenez AM, Rodrigo MAM, Milosavljevic V, Krizkova S, Kopel P, Heger Z, Adam V. Gold nanoparticles-modified nanomaghemite and quantum dots-based hybridization assay for detection of HPV. Sens Actuators, B Chem. 2017;240:503–10.</cite> [<a href="https://scholar.google.com/scholar_lookup?Jimenez%20Jimenez%20AM,%20Rodrigo%20MAM,%20Milosavljevic%20V,%20Krizkova%20S,%20Kopel%20P,%20Heger%20Z,%20Adam%20V.%20Gold%20nanoparticles-modified%20nanomaghemite%20and%20quantum%20dots-based%20hybridization%20assay%20for%20detection%20of%20HPV.%20Sens%20Actuators,%20B%20Chem.%202017;240:503%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Sin ML, Mach KE, Wong PK, Liao JC. Advances and challenges in biosensor-based diagnosis of infectious diseases. Expert Rev Mol Diagn. 2014;14:225–44.
</cite> [<a href="https://doi.org/10.1586/14737159.2014.888313" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4104499/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24524681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sin%20ML,%20Mach%20KE,%20Wong%20PK,%20Liao%20JC.%20Advances%20and%20challenges%20in%20biosensor-based%20diagnosis%20of%20infectious%20diseases.%20Expert%20Rev%20Mol%20Diagn.%202014;14:225%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Kah JC, Kho KW, Lee CG, James C, Sheppard R, Shen ZX, Soo KC, Olivo MC. Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles. Int J Nanomedicine. 2007;2:785–98.
</cite> [<a href="/articles/PMC2676812/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18203445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kah%20JC,%20Kho%20KW,%20Lee%20CG,%20James%20C,%20Sheppard%20R,%20Shen%20ZX,%20Soo%20KC,%20Olivo%20MC.%20Early%20diagnosis%20of%20oral%20cancer%20based%20on%20the%20surface%20plasmon%20resonance%20of%20gold%20nanoparticles.%20Int%20J%20Nanomedicine.%202007;2:785%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Kim CS, Wilder-Smith P, Ahn YC, Liaw LH, Chen Z, Kwon YJ. Enhanced detection of early-stage oral cancer <em>in vivo</em> by optical coherence tomography using multimodal delivery of gold nanoparticles. J Biomed Opt. 2009;14: 034008.
</cite> [<a href="https://doi.org/10.1117/1.3130323" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2872553/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19566301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20CS,%20Wilder-Smith%20P,%20Ahn%20YC,%20Liaw%20LH,%20Chen%20Z,%20Kwon%20YJ.%20Enhanced%20detection%20of%20early-stage%20oral%20cancer%20in%20vivo%20by%20optical%20coherence%20tomography%20using%20multimodal%20delivery%20of%20gold%20nanoparticles.%20J%20Biomed%20Opt.%202009;14:%20034008." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Luke GP, Myers JN, Emelianov SY, Sokolov KV. Sentinel lymph node biopsy revisited: ultrasound-guided photoacoustic detection of micrometastases using molecularly targeted plasmonic nanosensors. Cancer Res. 2014;74:5397–408.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-14-0796" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4198334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25106426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luke%20GP,%20Myers%20JN,%20Emelianov%20SY,%20Sokolov%20KV.%20Sentinel%20lymph%20node%20biopsy%20revisited:%20ultrasound-guided%20photoacoustic%20detection%20of%20micrometastases%20using%20molecularly%20targeted%20plasmonic%20nanosensors.%20Cancer%20Res.%202014;74:5397%E2%80%93408." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Khademi S, Sarkar S, Shakeri-Zadeh A, Attaran N, Kharrazi S, Ay MR, Azimian H, Ghadiri H. Targeted gold nanoparticles enable molecular CT imaging of head and neck cancer: an in vivo study. Int J Biochem Cell Biol. 2019;114: 105554.
</cite> [<a href="https://doi.org/10.1016/j.biocel.2019.06.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31276787/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Khademi%20S,%20Sarkar%20S,%20Shakeri-Zadeh%20A,%20Attaran%20N,%20Kharrazi%20S,%20Ay%20MR,%20Azimian%20H,%20Ghadiri%20H.%20Targeted%20gold%20nanoparticles%20enable%20molecular%20CT%20imaging%20of%20head%20and%20neck%20cancer:%20an%20in%20vivo%20study.%20Int%20J%20Biochem%20Cell%20Biol.%202019;114:%20105554." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Ankri R, Ashkenazy A, Milstein Y, Brami Y, Olshinka A, Goldenberg-Cohen N, Popovtzer A, Fixler D, Hirshberg A. Gold nanorods based air scanning electron microscopy and diffusion reflection imaging for mapping tumor margins in squamous cell carcinoma. ACS Nano. 2016;10:2349–56.
</cite> [<a href="https://doi.org/10.1021/acsnano.5b07114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26759920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ankri%20R,%20Ashkenazy%20A,%20Milstein%20Y,%20Brami%20Y,%20Olshinka%20A,%20Goldenberg-Cohen%20N,%20Popovtzer%20A,%20Fixler%20D,%20Hirshberg%20A.%20Gold%20nanorods%20based%20air%20scanning%20electron%20microscopy%20and%20diffusion%20reflection%20imaging%20for%20mapping%20tumor%20margins%20in%20squamous%20cell%20carcinoma.%20ACS%20Nano.%202016;10:2349%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Chen L, Kong Q, Tian M, Zhang Q, Xia C, Deng C. Zn(0.4)Mg(0.6)Fe(2)O(4) nanoenzyme: a novel chemo-sensitizer for the chemotherapy treatment of oral squamous cell carcinoma. Nanoscale Adv. 2023;5:851–60.
</cite> [<a href="https://doi.org/10.1039/d2na00750a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9890649/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36756528/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20L,%20Kong%20Q,%20Tian%20M,%20Zhang%20Q,%20Xia%20C,%20Deng%20C.%20Zn(0.4)Mg(0.6)Fe(2)O(4)%20nanoenzyme:%20a%20novel%20chemo-sensitizer%20for%20the%20chemotherapy%20treatment%20of%20oral%20squamous%20cell%20carcinoma.%20Nanoscale%20Adv.%202023;5:851%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Xia C, Pan J, Wang J, Pu Y, Zhang Q, Hu S, Hu Q, Wang Y. Functional blockade of cancer-associated fibroblasts with ultrafine gold nanomaterials causes an unprecedented bystander antitumoral effect. Nanoscale. 2020;12:19833–43.
</cite> [<a href="https://doi.org/10.1039/d0nr04682e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32969446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xia%20C,%20Pan%20J,%20Wang%20J,%20Pu%20Y,%20Zhang%20Q,%20Hu%20S,%20Hu%20Q,%20Wang%20Y.%20Functional%20blockade%20of%20cancer-associated%20fibroblasts%20with%20ultrafine%20gold%20nanomaterials%20causes%20an%20unprecedented%20bystander%20antitumoral%20effect.%20Nanoscale.%202020;12:19833%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Kashin M, Kakei Y, Teraoka S, Hasegawa T, Yamaguchi A, Fukuoka T, Sasaki R, Akashi M. Gold Nanoparticles Enhance EGFR Inhibition and Irradiation Effects in Head and Neck Squamous Carcinoma Cells. Biomed Res Int. 2020;2020:1281645.
</cite> [<a href="https://doi.org/10.1155/2020/1281645" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7666624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33204681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kashin%20M,%20Kakei%20Y,%20Teraoka%20S,%20Hasegawa%20T,%20Yamaguchi%20A,%20Fukuoka%20T,%20Sasaki%20R,%20Akashi%20M.%20Gold%20Nanoparticles%20Enhance%20EGFR%20Inhibition%20and%20Irradiation%20Effects%20in%20Head%20and%20Neck%20Squamous%20Carcinoma%20Cells.%20Biomed%20Res%20Int.%202020;2020:1281645." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Chen Y, Yang J, Fu S, Wu J. Gold nanoparticles as radiosensitizers in cancer radiotherapy. Int J Nanomed. 2020;15:9407–30.</cite> [<a href="https://doi.org/10.2147/IJN.S272902" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7699443/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33262595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20Y,%20Yang%20J,%20Fu%20S,%20Wu%20J.%20Gold%20nanoparticles%20as%20radiosensitizers%20in%20cancer%20radiotherapy.%20Int%20J%20Nanomed.%202020;15:9407%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Demir Duman F, Sebek M, Thanh NTK, Loizidou M, Shakib K, MacRobert AJ. Enhanced photodynamic therapy and fluorescence imaging using gold nanorods for porphyrin delivery in a novel in vitro squamous cell carcinoma 3D model. J Mater Chem B. 2020;8:5131–42.
</cite> [<a href="https://doi.org/10.1039/d0tb00810a" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32420578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Demir%20Duman%20F,%20Sebek%20M,%20Thanh%20NTK,%20Loizidou%20M,%20Shakib%20K,%20MacRobert%20AJ.%20Enhanced%20photodynamic%20therapy%20and%20fluorescence%20imaging%20using%20gold%20nanorods%20for%20porphyrin%20delivery%20in%20a%20novel%20in%20vitro%20squamous%20cell%20carcinoma%203D%20model.%20J%20Mater%20Chem%20B.%202020;8:5131%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Dai H, Yan H, Dong F, Zhang L, Du N, Sun L, Li N, Yu G, Yang Z, Wang Y, Huang M. Tumor-targeted biomimetic nanoplatform precisely integrates photodynamic therapy and autophagy inhibition for collaborative treatment of oral cancer. Biomater Sci. 2022;10:1456–69.
</cite> [<a href="https://doi.org/10.1039/d1bm01780b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35048086/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dai%20H,%20Yan%20H,%20Dong%20F,%20Zhang%20L,%20Du%20N,%20Sun%20L,%20Li%20N,%20Yu%20G,%20Yang%20Z,%20Wang%20Y,%20Huang%20M.%20Tumor-targeted%20biomimetic%20nanoplatform%20precisely%20integrates%20photodynamic%20therapy%20and%20autophagy%20inhibition%20for%20collaborative%20treatment%20of%20oral%20cancer.%20Biomater%20Sci.%202022;10:1456%E2%80%9369." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Zhang Y, Cong L, He J, Wang Y, Zou Y, Yang Z, Hu Y, Zhang S, He X. Photothermal treatment with EGFRmAb-AuNPs induces apoptosis in hypopharyngeal carcinoma cells via PI3K/AKT/mTOR and DNA damage response pathways. Acta Biochim Biophys Sin (Shanghai). 2018;50:567–78.
</cite> [<a href="https://doi.org/10.1093/abbs/gmy046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29718150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Y,%20Cong%20L,%20He%20J,%20Wang%20Y,%20Zou%20Y,%20Yang%20Z,%20Hu%20Y,%20Zhang%20S,%20He%20X.%20Photothermal%20treatment%20with%20EGFRmAb-AuNPs%20induces%20apoptosis%20in%20hypopharyngeal%20carcinoma%20cells%20via%20PI3K/AKT/mTOR%20and%20DNA%20damage%20response%20pathways.%20Acta%20Biochim%20Biophys%20Sin%20(Shanghai).%202018;50:567%E2%80%9378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Zeng S, Liu S, Lan Y, Qiu T, Zhou M, Gao W, Huang W, Ge L, Zhang J. Combined photothermotherapy and chemotherapy of oral squamous cell carcinoma guided by multifunctional nanomaterials enhanced photoacoustic tomography. Int J Nanomed. 2021;16:7373–90.</cite> [<a href="https://doi.org/10.2147/IJN.S336788" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8572119/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34754191/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zeng%20S,%20Liu%20S,%20Lan%20Y,%20Qiu%20T,%20Zhou%20M,%20Gao%20W,%20Huang%20W,%20Ge%20L,%20Zhang%20J.%20Combined%20photothermotherapy%20and%20chemotherapy%20of%20oral%20squamous%20cell%20carcinoma%20guided%20by%20multifunctional%20nanomaterials%20enhanced%20photoacoustic%20tomography.%20Int%20J%20Nanomed.%202021;16:7373%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Zhang L, Pan K, Huang S, Zhang X, Zhu X, He Y, Chen X, Tang Y, Yuan L, Yu D. Graphdiyne oxide-mediated photodynamic therapy boosts enhancive T-cell immune responses by increasing cellular stiffness. Int J Nanomed. 2023;18:797–812.</cite> [<a href="https://doi.org/10.2147/IJN.S392998" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9939947/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36814858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20L,%20Pan%20K,%20Huang%20S,%20Zhang%20X,%20Zhu%20X,%20He%20Y,%20Chen%20X,%20Tang%20Y,%20Yuan%20L,%20Yu%20D.%20Graphdiyne%20oxide-mediated%20photodynamic%20therapy%20boosts%20enhancive%20T-cell%20immune%20responses%20by%20increasing%20cellular%20stiffness.%20Int%20J%20Nanomed.%202023;18:797%E2%80%93812." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Wang YP, Liu IJ, Chung MJ, Wu HC. Novel anti-EGFR scFv human antibody-conjugated immunoliposomes enhance chemotherapeutic efficacy in squamous cell carcinoma of head and neck. Oral Oncol. 2020;106: 104689.
</cite> [<a href="https://doi.org/10.1016/j.oraloncology.2020.104689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32330686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20YP,%20Liu%20IJ,%20Chung%20MJ,%20Wu%20HC.%20Novel%20anti-EGFR%20scFv%20human%20antibody-conjugated%20immunoliposomes%20enhance%20chemotherapeutic%20efficacy%20in%20squamous%20cell%20carcinoma%20of%20head%20and%20neck.%20Oral%20Oncol.%202020;106:%20104689." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Hao M, Li X, Zhang X, Tao B, Shi H, Wu J, Li Y, Li X, Li S, Wu H, et al. Tongue squamous cell carcinoma-targeting Au-HN-1 nanosystem for CT imaging and photothermal therapy. Int J Oral Sci. 2025;17:9.
</cite> [<a href="https://doi.org/10.1038/s41368-024-00343-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11729884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39805836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hao%20M,%20Li%20X,%20Zhang%20X,%20Tao%20B,%20Shi%20H,%20Wu%20J,%20Li%20Y,%20Li%20X,%20Li%20S,%20Wu%20H,%20et%20al.%20Tongue%20squamous%20cell%20carcinoma-targeting%20Au-HN-1%20nanosystem%20for%20CT%20imaging%20and%20photothermal%20therapy.%20Int%20J%20Oral%20Sci.%202025;17:9." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Yang CM, Chu TH, Tsai KW, Hsieh S, Kung ML. Phytochemically derived zingerone nanoparticles inhibit cell proliferation, invasion and metastasis in human oral squamous cell carcinoma. Biomedicines. 2022. 10.3390/biomedicines10020320.
</cite> [<a href="https://doi.org/10.3390/biomedicines10020320" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8869513/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35203529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20CM,%20Chu%20TH,%20Tsai%20KW,%20Hsieh%20S,%20Kung%20ML.%20Phytochemically%20derived%20zingerone%20nanoparticles%20inhibit%20cell%20proliferation,%20invasion%20and%20metastasis%20in%20human%20oral%20squamous%20cell%20carcinoma.%20Biomedicines.%202022.%2010.3390/biomedicines10020320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.
</cite> [<a href="https://doi.org/10.3322/caac.21763" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36633525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Siegel%20RL,%20Miller%20KD,%20Wagle%20NS,%20Jemal%20A.%20Cancer%20statistics,%202023.%20CA%20Cancer%20J%20Clin.%202023;73:17%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE, Zhao Z, Thapar V, Joyce JA, Krizhanovsky V, Lowe SW. Non-cell-autonomous tumor suppression by p53. Cell. 2013;153:449–60.
</cite> [<a href="https://doi.org/10.1016/j.cell.2013.03.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3702034/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23562644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lujambio%20A,%20Akkari%20L,%20Simon%20J,%20Grace%20D,%20Tschaharganeh%20DF,%20Bolden%20JE,%20Zhao%20Z,%20Thapar%20V,%20Joyce%20JA,%20Krizhanovsky%20V,%20Lowe%20SW.%20Non-cell-autonomous%20tumor%20suppression%20by%20p53.%20Cell.%202013;153:449%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423–37.
</cite> [<a href="https://doi.org/10.1038/nm.3394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3954707/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24202395/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Quail%20DF,%20Joyce%20JA.%20Microenvironmental%20regulation%20of%20tumor%20progression%20and%20metastasis.%20Nat%20Med.%202013;19:1423%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Scherz-Shouval R, Santagata S, Mendillo ML, Sholl LM, Ben-Aharon I, Beck AH, Dias-Santagata D, Koeva M, Stemmer SM, Whitesell L, Lindquist S. The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy. Cell. 2014;158:564–78.
</cite> [<a href="https://doi.org/10.1016/j.cell.2014.05.045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4249939/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25083868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Scherz-Shouval%20R,%20Santagata%20S,%20Mendillo%20ML,%20Sholl%20LM,%20Ben-Aharon%20I,%20Beck%20AH,%20Dias-Santagata%20D,%20Koeva%20M,%20Stemmer%20SM,%20Whitesell%20L,%20Lindquist%20S.%20The%20reprogramming%20of%20tumor%20stroma%20by%20HSF1%20is%20a%20potent%20enabler%20of%20malignancy.%20Cell.%202014;158:564%E2%80%9378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Alhussan A, Bozdoğan EPD, Chithrani DB. Combining gold nanoparticles with other radiosensitizing agents for unlocking the full potential of cancer radiotherapy. Pharmaceutics. 2021;13(4):442.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics13040442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8064393/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33805917/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alhussan%20A,%20Bozdo%C4%9Fan%20EPD,%20Chithrani%20DB.%20Combining%20gold%20nanoparticles%20with%20other%20radiosensitizing%20agents%20for%20unlocking%20the%20full%20potential%20of%20cancer%20radiotherapy.%20Pharmaceutics.%202021;13(4):442." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Hazkani I, Motiei M, Betzer O, Sadan T, Bragilovski D, Lubimov L, Mizrachi A, Hadar T, Levi M, Ben-Aharon I, et al. Can molecular profiling enhance radiotherapy? Impact of personalized targeted gold nanoparticles on radiosensitivity and imaging of adenoid cystic carcinoma. Theranostics. 2017;7:3962–71.
</cite> [<a href="https://doi.org/10.7150/thno.19615" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5667418/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29109791/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hazkani%20I,%20Motiei%20M,%20Betzer%20O,%20Sadan%20T,%20Bragilovski%20D,%20Lubimov%20L,%20Mizrachi%20A,%20Hadar%20T,%20Levi%20M,%20Ben-Aharon%20I,%20et%20al.%20Can%20molecular%20profiling%20enhance%20radiotherapy?%20Impact%20of%20personalized%20targeted%20gold%20nanoparticles%20on%20radiosensitivity%20and%20imaging%20of%20adenoid%20cystic%20carcinoma.%20Theranostics.%202017;7:3962%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Piccolo O, Lincoln JD, Melong N, Orr BC, Fernandez NR, Borsavage J, Berman JN, Robar J, Ha MN. Radiation dose enhancement using gold nanoparticles with a diamond linear accelerator target: a multiple cell type analysis. Sci Rep. 2022;12: 1559.
</cite> [<a href="https://doi.org/10.1038/s41598-022-05339-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8799734/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35091583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Piccolo%20O,%20Lincoln%20JD,%20Melong%20N,%20Orr%20BC,%20Fernandez%20NR,%20Borsavage%20J,%20Berman%20JN,%20Robar%20J,%20Ha%20MN.%20Radiation%20dose%20enhancement%20using%20gold%20nanoparticles%20with%20a%20diamond%20linear%20accelerator%20target:%20a%20multiple%20cell%20type%20analysis.%20Sci%20Rep.%202022;12:%201559." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Davidi ES, Dreifuss T, Motiei M, Shai E, Bragilovski D, Lubimov L, Kindler MJJ, Popovtzer A, Don J, Popovtzer R. Cisplatin-conjugated gold nanoparticles as a theranostic agent for head and neck cancer. Head Neck. 2018;40:70–8.
</cite> [<a href="https://doi.org/10.1002/hed.24935" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29130566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Davidi%20ES,%20Dreifuss%20T,%20Motiei%20M,%20Shai%20E,%20Bragilovski%20D,%20Lubimov%20L,%20Kindler%20MJJ,%20Popovtzer%20A,%20Don%20J,%20Popovtzer%20R.%20Cisplatin-conjugated%20gold%20nanoparticles%20as%20a%20theranostic%20agent%20for%20head%20and%20neck%20cancer.%20Head%20Neck.%202018;40:70%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Su J, Lu S, Jiang S, Li B, Liu B, Sun Q, Li J, Wang F, Wei Y. Engineered protein photo-thermal hydrogels for outstanding in situ tongue cancer therapy. Adv Mater. 2021;33: e2100619.
</cite> [<a href="https://doi.org/10.1002/adma.202100619" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33861490/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Su%20J,%20Lu%20S,%20Jiang%20S,%20Li%20B,%20Liu%20B,%20Sun%20Q,%20Li%20J,%20Wang%20F,%20Wei%20Y.%20Engineered%20protein%20photo-thermal%20hydrogels%20for%20outstanding%20in%20situ%20tongue%20cancer%20therapy.%20Adv%20Mater.%202021;33:%20e2100619." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Toratani S, Tani R, Kanda T, Koizumi K, Yoshioka Y, Okamoto T. Photodynamic therapy using Photofrin and excimer dye laser treatment for superficial oral squamous cell carcinomas with long-term follow up. Photodiagnosis Photodyn Ther. 2016;14:104–10.
</cite> [<a href="https://doi.org/10.1016/j.pdpdt.2015.12.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26747657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Toratani%20S,%20Tani%20R,%20Kanda%20T,%20Koizumi%20K,%20Yoshioka%20Y,%20Okamoto%20T.%20Photodynamic%20therapy%20using%20Photofrin%20and%20excimer%20dye%20laser%20treatment%20for%20superficial%20oral%20squamous%20cell%20carcinomas%20with%20long-term%20follow%20up.%20Photodiagnosis%20Photodyn%20Ther.%202016;14:104%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Chilakamarthi U, Giribabu L. Photodynamic therapy: past, present and future. Chem Rec. 2017;17:775–802.
</cite> [<a href="https://doi.org/10.1002/tcr.201600121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28042681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chilakamarthi%20U,%20Giribabu%20L.%20Photodynamic%20therapy:%20past,%20present%20and%20future.%20Chem%20Rec.%202017;17:775%E2%80%93802." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Ferreira DC, Monteiro CS, Chaves CR, Sáfar GAM, Moreira RL, Pinheiro MVB, Martins DCS, Ladeira LO, Krambrock K. Hybrid systems based on gold nanostructures and porphyrins as promising photosensitizers for photodynamic therapy. Coll Surf B Biointerfaces. 2017;150:297–307.</cite> [<a href="https://doi.org/10.1016/j.colsurfb.2016.10.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28029548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferreira%20DC,%20Monteiro%20CS,%20Chaves%20CR,%20S%C3%A1far%20GAM,%20Moreira%20RL,%20Pinheiro%20MVB,%20Martins%20DCS,%20Ladeira%20LO,%20Krambrock%20K.%20Hybrid%20systems%20based%20on%20gold%20nanostructures%20and%20porphyrins%20as%20promising%20photosensitizers%20for%20photodynamic%20therapy.%20Coll%20Surf%20B%20Biointerfaces.%202017;150:297%E2%80%93307." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Chi YF, Qin JJ, Li Z, Ge Q, Zeng WH. Enhanced anti-tumor efficacy of 5-aminolevulinic acid-gold nanoparticles-mediated photodynamic therapy in cutaneous squamous cell carcinoma cells. Braz J Med Biol Res. 2020;53: e8457.
</cite> [<a href="https://doi.org/10.1590/1414-431X20208457" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7205413/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32348428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chi%20YF,%20Qin%20JJ,%20Li%20Z,%20Ge%20Q,%20Zeng%20WH.%20Enhanced%20anti-tumor%20efficacy%20of%205-aminolevulinic%20acid-gold%20nanoparticles-mediated%20photodynamic%20therapy%20in%20cutaneous%20squamous%20cell%20carcinoma%20cells.%20Braz%20J%20Med%20Biol%20Res.%202020;53:%20e8457." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Xia B, Wang B, Shi J, Zhang Y, Zhang Q, Chen Z, Li J. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer. Acta Biomater. 2017;51:197–208.
</cite> [<a href="https://doi.org/10.1016/j.actbio.2017.01.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28069501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xia%20B,%20Wang%20B,%20Shi%20J,%20Zhang%20Y,%20Zhang%20Q,%20Chen%20Z,%20Li%20J.%20Photothermal%20and%20biodegradable%20polyaniline/porous%20silicon%20hybrid%20nanocomposites%20as%20drug%20carriers%20for%20combined%20chemo-photothermal%20therapy%20of%20cancer.%20Acta%20Biomater.%202017;51:197%E2%80%93208." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Wei W, Zhang X, Zhang S, Wei G, Su Z. Biomedical and bioactive engineered nanomaterials for targeted tumor photothermal therapy: a review. Mater Sci Eng C Mater Biol Appl. 2019;104: 109891.
</cite> [<a href="https://doi.org/10.1016/j.msec.2019.109891" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31500035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei%20W,%20Zhang%20X,%20Zhang%20S,%20Wei%20G,%20Su%20Z.%20Biomedical%20and%20bioactive%20engineered%20nanomaterials%20for%20targeted%20tumor%20photothermal%20therapy:%20a%20review.%20Mater%20Sci%20Eng%20C%20Mater%20Biol%20Appl.%202019;104:%20109891." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res. 2005;127:208–23.
</cite> [<a href="https://doi.org/10.1016/j.jss.2005.02.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16083756/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nikfarjam%20M,%20Muralidharan%20V,%20Christophi%20C.%20Mechanisms%20of%20focal%20heat%20destruction%20of%20liver%20tumors.%20J%20Surg%20Res.%202005;127:208%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Zou L, Wang H, He B, Zeng L, Tan T, Cao H, He X, Zhang Z, Guo S, Li Y. Current approaches of photothermal therapy in treating cancer metastasis with nanotherapeutics. Theranostics. 2016;6:762–72.
</cite> [<a href="https://doi.org/10.7150/thno.14988" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4860886/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27162548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zou%20L,%20Wang%20H,%20He%20B,%20Zeng%20L,%20Tan%20T,%20Cao%20H,%20He%20X,%20Zhang%20Z,%20Guo%20S,%20Li%20Y.%20Current%20approaches%20of%20photothermal%20therapy%20in%20treating%20cancer%20metastasis%20with%20nanotherapeutics.%20Theranostics.%202016;6:762%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Egnuni T, Ingram N, Mirza I, Coletta PL, McLaughlan JR. Evaluation of the targeting and therapeutic efficiency of anti-EGFR functionalised nanoparticles in head and neck cancer cells for use in NIR-II optical window. Pharmaceutics. 2021;13(10):1651.
</cite> [<a href="https://doi.org/10.3390/pharmaceutics13101651" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8537270/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34683944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Egnuni%20T,%20Ingram%20N,%20Mirza%20I,%20Coletta%20PL,%20McLaughlan%20JR.%20Evaluation%20of%20the%20targeting%20and%20therapeutic%20efficiency%20of%20anti-EGFR%20functionalised%20nanoparticles%20in%20head%20and%20neck%20cancer%20cells%20for%20use%20in%20NIR-II%20optical%20window.%20Pharmaceutics.%202021;13(10):1651." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Gröhl J, Schellenberg M, Dreher K, Maier-Hein L. Deep learning for biomedical photoacoustic imaging: a review. Photoacoustics. 2021;22: 100241.
</cite> [<a href="https://doi.org/10.1016/j.pacs.2021.100241" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7932894/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33717977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gr%C3%B6hl%20J,%20Schellenberg%20M,%20Dreher%20K,%20Maier-Hein%20L.%20Deep%20learning%20for%20biomedical%20photoacoustic%20imaging:%20a%20review.%20Photoacoustics.%202021;22:%20100241." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Al Qaraghuli MM. Biotherapeutic antibodies for the treatment of head and neck cancer: current approaches and future considerations of photothermal therapies. Front Oncol. 2020;10: 559596.
</cite> [<a href="https://doi.org/10.3389/fonc.2020.559596" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7726427/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33324546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Al%20Qaraghuli%20MM.%20Biotherapeutic%20antibodies%20for%20the%20treatment%20of%20head%20and%20neck%20cancer:%20current%20approaches%20and%20future%20considerations%20of%20photothermal%20therapies.%20Front%20Oncol.%202020;10:%20559596." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Lv J, Liu Y, Cheng F, Li J, Zhou Y, Zhang T, Zhou N, Li C, Wang Z, Ma L, et al. Cell softness regulates tumorigenicity and stemness of cancer cells. EMBO J. 2021;40: e106123.
</cite> [<a href="https://doi.org/10.15252/embj.2020106123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7809788/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33274785/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lv%20J,%20Liu%20Y,%20Cheng%20F,%20Li%20J,%20Zhou%20Y,%20Zhang%20T,%20Zhou%20N,%20Li%20C,%20Wang%20Z,%20Ma%20L,%20et%20al.%20Cell%20softness%20regulates%20tumorigenicity%20and%20stemness%20of%20cancer%20cells.%20EMBO%20J.%202021;40:%20e106123." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Ruiz-Pulido G, Medina DI, Barani M, Rahdar A, Sargazi G, Baino F, Pandey S. Nanomaterials for the diagnosis and treatment of head and neck cancers: a review. Materials. 2021. 10.3390/ma14133706.
</cite> [<a href="https://doi.org/10.3390/ma14133706" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8269895/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34279276/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ruiz-Pulido%20G,%20Medina%20DI,%20Barani%20M,%20Rahdar%20A,%20Sargazi%20G,%20Baino%20F,%20Pandey%20S.%20Nanomaterials%20for%20the%20diagnosis%20and%20treatment%20of%20head%20and%20neck%20cancers:%20a%20review.%20Materials.%202021.%2010.3390/ma14133706." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Fu Z, Xiang J. Aptamer-functionalized nanoparticles in targeted delivery and cancer therapy. Int J Mol Sci. 2020. 10.3390/ijms21239123.
</cite> [<a href="https://doi.org/10.3390/ijms21239123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7730239/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33266216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fu%20Z,%20Xiang%20J.%20Aptamer-functionalized%20nanoparticles%20in%20targeted%20delivery%20and%20cancer%20therapy.%20Int%20J%20Mol%20Sci.%202020.%2010.3390/ijms21239123." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Gotov O, Battogtokh G, Shin D, Ko YT. Hyaluronic acid-coated cisplatin conjugated gold nanoparticles for com bined cancer treatment. J Ind Eng Chem. 2018;65:236–43.</cite> [<a href="https://scholar.google.com/scholar_lookup?Gotov%20O,%20Battogtokh%20G,%20Shin%20D,%20Ko%20YT.%20Hyaluronic%20acid-coated%20cisplatin%20conjugated%20gold%20nanoparticles%20for%20com%20bined%20cancer%20treatment.%20J%20Ind%20Eng%20Chem.%202018;65:236%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Ahmad B, Rehman MU, Amin I, Arif A, Rasool S, Bhat SA, Afzal I, Hussain I, Bilal S, Mir M. A review on pharmacological properties of zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone). Sci World J. 2015;2015: 816364.</cite> [<a href="https://doi.org/10.1155/2015/816364" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4461790/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26106644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ahmad%20B,%20Rehman%20MU,%20Amin%20I,%20Arif%20A,%20Rasool%20S,%20Bhat%20SA,%20Afzal%20I,%20Hussain%20I,%20Bilal%20S,%20Mir%20M.%20A%20review%20on%20pharmacological%20properties%20of%20zingerone%20(4-(4-Hydroxy-3-methoxyphenyl)-2-butanone).%20Sci%20World%20J.%202015;2015:%20816364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Mahapatra C, Lee R, Paul MK. Emerging role and promise of nanomaterials in organoid research. Drug Discov Today. 2022;27:890–9.
</cite> [<a href="https://doi.org/10.1016/j.drudis.2021.11.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34774765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mahapatra%20C,%20Lee%20R,%20Paul%20MK.%20Emerging%20role%20and%20promise%20of%20nanomaterials%20in%20organoid%20research.%20Drug%20Discov%20Today.%202022;27:890%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>Lo JH, Hao L, Muzumdar MD, Raghavan S, Kwon EJ, Pulver EM, Hsu F, Aguirre AJ, Wolpin BM, Fuchs CS, et al. iRGD-guided tumor-penetrating nanocomplexes for therapeutic siRNA delivery to pancreatic cancer. Mol Cancer Ther. 2018;17:2377–88.
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-17-1090" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6298224/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30097486/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lo%20JH,%20Hao%20L,%20Muzumdar%20MD,%20Raghavan%20S,%20Kwon%20EJ,%20Pulver%20EM,%20Hsu%20F,%20Aguirre%20AJ,%20Wolpin%20BM,%20Fuchs%20CS,%20et%20al.%20iRGD-guided%20tumor-penetrating%20nanocomplexes%20for%20therapeutic%20siRNA%20delivery%20to%20pancreatic%20cancer.%20Mol%20Cancer%20Ther.%202018;17:2377%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>McCarthy B, Cudykier A, Singh R, Levi-Polyachenko N, Soker S. Semiconducting polymer nanoparticles for photothermal ablation of colorectal cancer organoids. Sci Rep. 2021;11:1532.
</cite> [<a href="https://doi.org/10.1038/s41598-021-81122-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7810691/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33452397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McCarthy%20B,%20Cudykier%20A,%20Singh%20R,%20Levi-Polyachenko%20N,%20Soker%20S.%20Semiconducting%20polymer%20nanoparticles%20for%20photothermal%20ablation%20of%20colorectal%20cancer%20organoids.%20Sci%20Rep.%202021;11:1532." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Parvani JG, Gujrati MD, Mack MA, Schiemann WP, Lu ZR. Silencing β3 integrin by targeted ECO/siRNA nanoparticles inhibits EMT and metastasis of triple-negative breast cancer. Cancer Res. 2015;75:2316–25.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-14-3485" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4452414/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25858145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Parvani%20JG,%20Gujrati%20MD,%20Mack%20MA,%20Schiemann%20WP,%20Lu%20ZR.%20Silencing%20%CE%B23%20integrin%20by%20targeted%20ECO/siRNA%20nanoparticles%20inhibits%20EMT%20and%20metastasis%20of%20triple-negative%20breast%20cancer.%20Cancer%20Res.%202015;75:2316%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR96">
<span class="label">96.</span><cite>Kwak B, Ozcelikkale A, Shin CS, Park K, Han B. Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip. J Control Release. 2014;194:157–67.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2014.08.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4252353/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25194778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kwak%20B,%20Ozcelikkale%20A,%20Shin%20CS,%20Park%20K,%20Han%20B.%20Simulation%20of%20complex%20transport%20of%20nanoparticles%20around%20a%20tumor%20using%20tumor-microenvironment-on-chip.%20J%20Control%20Release.%202014;194:157%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9: 1410.
</cite> [<a href="https://doi.org/10.1038/s41467-018-03705-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5897557/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29650952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rosenblum%20D,%20Joshi%20N,%20Tao%20W,%20Karp%20JM,%20Peer%20D.%20Progress%20and%20challenges%20towards%20targeted%20delivery%20of%20cancer%20therapeutics.%20Nat%20Commun.%202018;9:%201410." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR98">
<span class="label">98.</span><cite>He H, Liu L, Morin EE, Liu M, Schwendeman A. Survey of clinical translation of cancer nanomedicines-lessons learned from successes and failures. Acc Chem Res. 2019;52:2445–61.
</cite> [<a href="https://doi.org/10.1021/acs.accounts.9b00228" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31424909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?He%20H,%20Liu%20L,%20Morin%20EE,%20Liu%20M,%20Schwendeman%20A.%20Survey%20of%20clinical%20translation%20of%20cancer%20nanomedicines-lessons%20learned%20from%20successes%20and%20failures.%20Acc%20Chem%20Res.%202019;52:2445%E2%80%9361." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Pilot Feasibility Study of Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI for Primary and Nodal Tumor Imaging in Locally Advanced Head and Neck Squamous Cell Carcinomas. 2013.</cite>
</li>
<li id="CR100">
<span class="label">100.</span><cite>Phase II Study of NBTXR3 Activated by Radiation and Combined With Pembrolizumab for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma With Limited PD-L1 Expression or Refractory to PD-1 Blockade. 2021.</cite>
</li>
<li id="CR101">
<span class="label">101.</span><cite>Nedzi LA, Sumer B, Myers L, Truelson J, Hughes R, Young G, Choy H. Phase I study of nab-paclitaxel, cisplatin and cetuximab with concurrent radiation therapy for local-regionally advanced head and neck squamous cell carcinoma (HNSCC). Int J Radiat Oncol, Biol, Phys. 2010;78(3):S440s.</cite> [<a href="https://scholar.google.com/scholar_lookup?Nedzi%20LA,%20Sumer%20B,%20Myers%20L,%20Truelson%20J,%20Hughes%20R,%20Young%20G,%20Choy%20H.%20Phase%20I%20study%20of%20nab-paclitaxel,%20cisplatin%20and%20cetuximab%20with%20concurrent%20radiation%20therapy%20for%20local-regionally%20advanced%20head%20and%20neck%20squamous%20cell%20carcinoma%20(HNSCC).%20Int%20J%20Radiat%20Oncol,%20Biol,%20Phys.%202010;78(3):S440s." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR102">
<span class="label">102.</span><cite>Fury MG, Sherman EJ, Rao SS, Wolden S, Smith-Marrone S, Mueller B, Ng KK, et al. Phase I study of weekly nab-paclitaxel+ weekly cetuximab+ intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC). Ann Oncol. 2014;25(3):689–94.
</cite> [<a href="https://doi.org/10.1093/annonc/mdt579" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4433511/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24496920/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fury%20MG,%20Sherman%20EJ,%20Rao%20SS,%20Wolden%20S,%20Smith-Marrone%20S,%20Mueller%20B,%20Ng%20KK,%20et%20al.%20Phase%20I%20study%20of%20weekly%20nab-paclitaxel+%20weekly%20cetuximab+%20intensity-modulated%20radiation%20therapy%20(IMRT)%20in%20patients%20with%20stage%20III%E2%80%93IVB%20head%20and%20neck%20squamous%20cell%20carcinoma%20(HNSCC).%20Ann%20Oncol.%202014;25(3):689%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>A Phase II Study of Reirradiation With NBTXR3 in Patients With Inoperable Locoregional Recurrent Head and Neck Squamous Cell Carcinoma. 2021.</cite>
</li>
<li id="CR104">
<span class="label">104.</span><cite>Phase II Trial of Nab-Paclitaxel, Cisplatin, and 5-FU (ACF) as Induction Therapy Followed by Definitive Concurrent Chemoradiation for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC). (Celgene ed.; 2012).</cite>
</li>
<li id="CR105">
<span class="label">105.</span><cite>Yom SS, Takacsi-Nagy Z, Liem X, Salas S, Debard A, Finzi L, Vivar OI, et al. NANORAY-312: a phase III pivotal study of NBTXR3 activated by investigator’s choice of radiotherapy alone or radiotherapy in combination with cetuximab for platinum-based chemotherapy-ineligible elderly patients with locally advanced HNSCC. Int J Radiat Oncol, Biol, Phys. 2022;114(3):e313.</cite> [<a href="https://scholar.google.com/scholar_lookup?Yom%20SS,%20Takacsi-Nagy%20Z,%20Liem%20X,%20Salas%20S,%20Debard%20A,%20Finzi%20L,%20Vivar%20OI,%20et%20al.%20NANORAY-312:%20a%20phase%20III%20pivotal%20study%20of%20NBTXR3%20activated%20by%20investigator%E2%80%99s%20choice%20of%20radiotherapy%20alone%20or%20radiotherapy%20in%20combination%20with%20cetuximab%20for%20platinum-based%20chemotherapy-ineligible%20elderly%20patients%20with%20locally%20advanced%20HNSCC.%20Int%20J%20Radiat%20Oncol,%20Biol,%20Phys.%202022;114(3):e313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR106">
<span class="label">106.</span><cite>Phase I Study of NC-6004 in Combination With 5-FU and Cetuximab as First-line Treatment in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck. (NanoCarrier Co L ed.; 2016).</cite>
</li>
<li id="CR107">
<span class="label">107.</span><cite>A Phase 2 Study to Determine the Efficacy and Safety of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck. 2015.</cite>
</li>
<li id="CR108">
<span class="label">108.</span><cite>Nab-Paclitaxel-based Re-induction Chemotherapy Followed by Response-stratified Chemoradiotherapy in Patients With Previously Treated Squamous Cell Carcinoma of the Head and Neck. (National Cancer I ed.; 2013).</cite>
</li>
<li id="CR109">
<span class="label">109.</span><cite>Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line. 2022.</cite>
</li>
<li id="CR110">
<span class="label">110.</span><cite>A Phase II Trial of Nivolumab/Nab-paclitaxel/Carboplatin Induction Chemotherapy Followed by Response-stratified Locoregional Therapy for Patients With Locoregionally Advanced HPV-related Oropharyngeal Cancer- the OPTIMA II Trial. 2017.</cite>
</li>
<li id="CR111">
<span class="label">111.</span><cite>A Phase II Clinical Study of the Efficacy and Safety of Preoperative Sintilimab in Combination With Nab-paclitaxel and Cisplatin in Borderline Resectable Esophageal Squamous Carcinoma. (Innovent Biologics Co L, Limited CPG eds.); 2020.</cite>
</li>
<li id="CR112">
<span class="label">112.</span><cite>Baz, S. M., and S. F. Abd El-Ghani. (2017) Therapeutic Effect Of Luteolin Natural Extract Versus Its Nanoparticles On Tongue Squamous Cell Carcinoma Cell Line: In Vitro Study<strong>.</strong></cite>
</li>
<li id="CR113">
<span class="label">113.</span><cite>An Exploratory Pilot Study of Nab-paclitaxel Based Induction Chemotherapy Followed by Response-Stratified Locoregional Therapy for Patients With Stage III and IV HPV-Related Oropharyngeal Cancer - the OPTIMA HPV Trial. (National Cancer I ed.; 2014).</cite>
</li>
<li id="CR114">
<span class="label">114.</span><cite>Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases. 2014.</cite>
</li>
<li id="CR115">
<span class="label">115.</span><cite>A Single Center Phase IIa Study of Nanoparticle Albumin-bound Paclitaxel in Combination With Cisplatin in Advanced Nasopharyngeal Carcinoma. 2012.</cite>
</li>
<li id="CR116">
<span class="label">116.</span><cite>Gold Nanoparticles as Novel Biomarkers for Cancer Stem Cells in Salivary Gland Tumors: A Diagnostic and Prognostic Accuracy Study. 2021.</cite>
</li>
<li id="CR117">
<span class="label">117.</span><cite>The Efficacy and Safety of Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil, Concurrent Chemotherapy of Cisplatin and IMRT in Locoregionally Advanced Nasopharyngeal Carcinoma: A Prospective, Multi-centeric, Open, Non-controlled, Phase II Clinical Trial. (Second Affiliated Hospital of Guangxi Medical U, Guilin Medical University C, Liuzhou Workers H, Wuzhou Red Cross H eds.); 2019.</cite>
</li>
<li id="CR118">
<span class="label">118.</span><cite>TPC Versus GP Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced Nasopharyngeal Carcinoma, a Multi-center Phase II Randomized Trial. 2024.</cite>
</li>
<li id="CR119">
<span class="label">119.</span><cite>Jing B, Qian R, Jiang D, Gai Y, Liu Z, Guo F, Ren S, Gao Y, Lan X, An R. Extracellular vesicles-based pre-targeting strategy enables multi-modal imaging of orthotopic colon cancer and image-guided surgery. J Nanobiotechnology. 2021;19:151.
</cite> [<a href="https://doi.org/10.1186/s12951-021-00888-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8141172/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34022897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jing%20B,%20Qian%20R,%20Jiang%20D,%20Gai%20Y,%20Liu%20Z,%20Guo%20F,%20Ren%20S,%20Gao%20Y,%20Lan%20X,%20An%20R.%20Extracellular%20vesicles-based%20pre-targeting%20strategy%20enables%20multi-modal%20imaging%20of%20orthotopic%20colon%20cancer%20and%20image-guided%20surgery.%20J%20Nanobiotechnology.%202021;19:151." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR120">
<span class="label">120.</span><cite>Zhang L, Zhang M, Zhou L, Han Q, Chen X, Li S, Li L, Su Z, Wang C. Dual drug delivery and sequential release by amphiphilic Janus nanoparticles for liver cancer theranostics. Biomaterials. 2018;181:113–25.
</cite> [<a href="https://doi.org/10.1016/j.biomaterials.2018.07.060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30081302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20L,%20Zhang%20M,%20Zhou%20L,%20Han%20Q,%20Chen%20X,%20Li%20S,%20Li%20L,%20Su%20Z,%20Wang%20C.%20Dual%20drug%20delivery%20and%20sequential%20release%20by%20amphiphilic%20Janus%20nanoparticles%20for%20liver%20cancer%20theranostics.%20Biomaterials.%202018;181:113%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR121">
<span class="label">121.</span><cite>Qiu Y, Wu Z, Chen Y, Liao J, Zhang Q, Wang Q, Duan Y, Gong K, Chen S, Wang L, et al. Nano ultrasound contrast agent for synergistic chemo-photothermal therapy and enhanced immunotherapy against liver cancer and metastasis. Adv Sci (Weinh). 2023;10: e2300878.
</cite> [<a href="https://doi.org/10.1002/advs.202300878" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10375134/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37162268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiu%20Y,%20Wu%20Z,%20Chen%20Y,%20Liao%20J,%20Zhang%20Q,%20Wang%20Q,%20Duan%20Y,%20Gong%20K,%20Chen%20S,%20Wang%20L,%20et%20al.%20Nano%20ultrasound%20contrast%20agent%20for%20synergistic%20chemo-photothermal%20therapy%20and%20enhanced%20immunotherapy%20against%20liver%20cancer%20and%20metastasis.%20Adv%20Sci%20(Weinh).%202023;10:%20e2300878." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR122">
<span class="label">122.</span><cite>Ali A, Suhail M, Mathew S, Shah MA, Harakeh SM, Ahmad S, Kazmi Z, Alhamdan MA, Chaudhary A, Damanhouri GA, Qadri I. Nanomaterial induced immune responses and cytotoxicity. J Nanosci Nanotechnol. 2016;16:40–57.
</cite> [<a href="https://doi.org/10.1166/jnn.2016.10885" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27398432/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ali%20A,%20Suhail%20M,%20Mathew%20S,%20Shah%20MA,%20Harakeh%20SM,%20Ahmad%20S,%20Kazmi%20Z,%20Alhamdan%20MA,%20Chaudhary%20A,%20Damanhouri%20GA,%20Qadri%20I.%20Nanomaterial%20induced%20immune%20responses%20and%20cytotoxicity.%20J%20Nanosci%20Nanotechnol.%202016;16:40%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR123">
<span class="label">123.</span><cite>Sooklert K, Nilyai S, Rojanathanes R, Jindatip D, Sae-Liang N, Kitkumthorn N, Mutirangura A, Sereemaspun A. N-acetylcysteine reverses the decrease of DNA methylation status caused by engineered gold, silicon, and chitosan nanoparticles. Int J Nanomedicine. 2019;14:4573–87.
</cite> [<a href="https://doi.org/10.2147/IJN.S204372" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6599212/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31296987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sooklert%20K,%20Nilyai%20S,%20Rojanathanes%20R,%20Jindatip%20D,%20Sae-Liang%20N,%20Kitkumthorn%20N,%20Mutirangura%20A,%20Sereemaspun%20A.%20N-acetylcysteine%20reverses%20the%20decrease%20of%20DNA%20methylation%20status%20caused%20by%20engineered%20gold,%20silicon,%20and%20chitosan%20nanoparticles.%20Int%20J%20Nanomedicine.%202019;14:4573%E2%80%9387." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR124">
<span class="label">124.</span><cite>Xu L, Chu Z, Wang H, Cai L, Tu Z, Liu H, Zhu C, Shi H, Pan D, Pan J, Fei X. Electrostatically assembled multilayered films of biopolymer enhanced nanocapsules for on-demand drug release. ACS Appl Bio Mater. 2019;2:3429–38.
</cite> [<a href="https://doi.org/10.1021/acsabm.9b00381" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35030731/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20L,%20Chu%20Z,%20Wang%20H,%20Cai%20L,%20Tu%20Z,%20Liu%20H,%20Zhu%20C,%20Shi%20H,%20Pan%20D,%20Pan%20J,%20Fei%20X.%20Electrostatically%20assembled%20multilayered%20films%20of%20biopolymer%20enhanced%20nanocapsules%20for%20on-demand%20drug%20release.%20ACS%20Appl%20Bio%20Mater.%202019;2:3429%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR125">
<span class="label">125.</span><cite>Yu J, Wang J, Zhang Y, Chen G, Mao W, Ye Y, Kahkoska AR, Buse JB, Langer R, Gu Z. Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs. Nat Biomed Eng. 2020;4:499–506.
</cite> [<a href="https://doi.org/10.1038/s41551-019-0508-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7231631/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32015407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20J,%20Wang%20J,%20Zhang%20Y,%20Chen%20G,%20Mao%20W,%20Ye%20Y,%20Kahkoska%20AR,%20Buse%20JB,%20Langer%20R,%20Gu%20Z.%20Glucose-responsive%20insulin%20patch%20for%20the%20regulation%20of%20blood%20glucose%20in%20mice%20and%20minipigs.%20Nat%20Biomed%20Eng.%202020;4:499%E2%80%93506." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR126">
<span class="label">126.</span><cite>Caratelli V, Di Meo E, Colozza N, Fabiani L, Fiore L, Moscone D, Arduini F. Nanomaterials and paper-based electrochemical devices: merging strategies for fostering sustainable detection of biomarkers. J Mater Chem B. 2022;10:9021–39.
</cite> [<a href="https://doi.org/10.1039/d2tb00387b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35899594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Caratelli%20V,%20Di%20Meo%20E,%20Colozza%20N,%20Fabiani%20L,%20Fiore%20L,%20Moscone%20D,%20Arduini%20F.%20Nanomaterials%20and%20paper-based%20electrochemical%20devices:%20merging%20strategies%20for%20fostering%20sustainable%20detection%20of%20biomarkers.%20J%20Mater%20Chem%20B.%202022;10:9021%E2%80%9339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR127">
<span class="label">127.</span><cite>Lan H, Zhang W, Jin K, Liu Y, Wang Z. Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective. Drug Deliv. 2020;27:1248–62.
</cite> [<a href="https://doi.org/10.1080/10717544.2020.1809559" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7470050/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32865029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lan%20H,%20Zhang%20W,%20Jin%20K,%20Liu%20Y,%20Wang%20Z.%20Modulating%20barriers%20of%20tumor%20microenvironment%20through%20nanocarrier%20systems%20for%20improved%20cancer%20immunotherapy:%20a%20review%20of%20current%20status%20and%20future%20perspective.%20Drug%20Deliv.%202020;27:1248%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR128">
<span class="label">128.</span><cite>Li Z, Xu K, Qin L, Zhao D, Yang N, Wang D, Yang Y. Hollow nanomaterials in advanced drug delivery systems: from single- to multiple shells. Adv Mater. 2023;35: e2203890.
</cite> [<a href="https://doi.org/10.1002/adma.202203890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35998336/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Z,%20Xu%20K,%20Qin%20L,%20Zhao%20D,%20Yang%20N,%20Wang%20D,%20Yang%20Y.%20Hollow%20nanomaterials%20in%20advanced%20drug%20delivery%20systems:%20from%20single-%20to%20multiple%20shells.%20Adv%20Mater.%202023;35:%20e2203890." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR129">
<span class="label">129.</span><cite>Rao C, Shi S. Development of nanomaterials to target articular cartilage for osteoarthritis therapy. Front Mol Biosci. 2022;9: 900344.
</cite> [<a href="https://doi.org/10.3389/fmolb.2022.900344" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9402910/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36032667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rao%20C,%20Shi%20S.%20Development%20of%20nanomaterials%20to%20target%20articular%20cartilage%20for%20osteoarthritis%20therapy.%20Front%20Mol%20Biosci.%202022;9:%20900344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR130">
<span class="label">130.</span><cite>Han B, Song Y, Park J, Doh J. Nanomaterials to improve cancer immunotherapy based on ex vivo engineered T cells and NK cells. J Control Release. 2022;343:379–91.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2022.01.049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35124129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Han%20B,%20Song%20Y,%20Park%20J,%20Doh%20J.%20Nanomaterials%20to%20improve%20cancer%20immunotherapy%20based%20on%20ex%20vivo%20engineered%20T%20cells%20and%20NK%20cells.%20J%20Control%20Release.%202022;343:379%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR131">
<span class="label">131.</span><cite>Hou X, Tao Y, Pang Y, Li X, Jiang G, Liu Y. Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment. Int J Cancer. 2018;143:3050–60.
</cite> [<a href="https://doi.org/10.1002/ijc.31717" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29981170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hou%20X,%20Tao%20Y,%20Pang%20Y,%20Li%20X,%20Jiang%20G,%20Liu%20Y.%20Nanoparticle-based%20photothermal%20and%20photodynamic%20immunotherapy%20for%20tumor%20treatment.%20Int%20J%20Cancer.%202018;143:3050%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR132">
<span class="label">132.</span><cite>Irvine DJ, Dane EL. Enhancing cancer immunotherapy with nanomedicine. Nat Rev Immunol. 2020;20:321–34.
</cite> [<a href="https://doi.org/10.1038/s41577-019-0269-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7536618/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32005979/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Irvine%20DJ,%20Dane%20EL.%20Enhancing%20cancer%20immunotherapy%20with%20nanomedicine.%20Nat%20Rev%20Immunol.%202020;20:321%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR133">
<span class="label">133.</span><cite>Xu P, Liang F. Nanomaterial-based tumor photothermal immunotherapy. Int J Nanomedicine. 2020;15:9159–80.
</cite> [<a href="https://doi.org/10.2147/IJN.S249252" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7684030/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33244232/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20P,%20Liang%20F.%20Nanomaterial-based%20tumor%20photothermal%20immunotherapy.%20Int%20J%20Nanomedicine.%202020;15:9159%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR134">
<span class="label">134.</span><cite>Kwon J, Choi WJ, Jeong U, Jung W, Hwang I, Park KH, Ko SG, Park SM, Kotov NA, Yeom J. Recent advances in chiral nanomaterials with unique electric and magnetic properties. Nano Converg. 2022;9:32.
</cite> [<a href="https://doi.org/10.1186/s40580-022-00322-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9294134/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35851425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kwon%20J,%20Choi%20WJ,%20Jeong%20U,%20Jung%20W,%20Hwang%20I,%20Park%20KH,%20Ko%20SG,%20Park%20SM,%20Kotov%20NA,%20Yeom%20J.%20Recent%20advances%20in%20chiral%20nanomaterials%20with%20unique%20electric%20and%20magnetic%20properties.%20Nano%20Converg.%202022;9:32." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR135">
<span class="label">135.</span><cite>Liu Y, Zheng P. Preserving the CTLA-4 checkpoint for safer and more effective cancer immunotherapy. Trends Pharmacol Sci. 2020;41:4–12.
</cite> [<a href="https://doi.org/10.1016/j.tips.2019.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7210725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31836191/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Zheng%20P.%20Preserving%20the%20CTLA-4%20checkpoint%20for%20safer%20and%20more%20effective%20cancer%20immunotherapy.%20Trends%20Pharmacol%20Sci.%202020;41:4%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR136">
<span class="label">136.</span><cite>Uthaman S, Cutshaw G, Ghazvini S, Bardhan R. Nanomaterials for natural killer cell-based immunoimaging and immunotherapies in cancer. ACS Appl Mater Interfaces. 2022. 10.1021/acsami.2c08619.
</cite> [<a href="https://doi.org/10.1021/acsami.2c08619" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10176446/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36006784/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Uthaman%20S,%20Cutshaw%20G,%20Ghazvini%20S,%20Bardhan%20R.%20Nanomaterials%20for%20natural%20killer%20cell-based%20immunoimaging%20and%20immunotherapies%20in%20cancer.%20ACS%20Appl%20Mater%20Interfaces.%202022.%2010.1021/acsami.2c08619." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR137">
<span class="label">137.</span><cite>Kunovac A, Hathaway QA, Pinti MV, Goldsmith WT, Durr AJ, Fink GK, Nurkiewicz TR, Hollander JM. ROS promote epigenetic remodeling and cardiac dysfunction in offspring following maternal engineered nanomaterial (ENM) exposure. Part Fibre Toxicol. 2019;16:24.
</cite> [<a href="https://doi.org/10.1186/s12989-019-0310-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6582485/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31215478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kunovac%20A,%20Hathaway%20QA,%20Pinti%20MV,%20Goldsmith%20WT,%20Durr%20AJ,%20Fink%20GK,%20Nurkiewicz%20TR,%20Hollander%20JM.%20ROS%20promote%20epigenetic%20remodeling%20and%20cardiac%20dysfunction%20in%20offspring%20following%20maternal%20engineered%20nanomaterial%20(ENM)%20exposure.%20Part%20Fibre%20Toxicol.%202019;16:24." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR138">
<span class="label">138.</span><cite>Rao CY, Sun XY, Ouyang JM. Effects of physical properties of nano-sized hydroxyapatite crystals on cellular toxicity in renal epithelial cells. Mater Sci Eng C Mater Biol Appl. 2019;103: 109807.
</cite> [<a href="https://doi.org/10.1016/j.msec.2019.109807" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31349397/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rao%20CY,%20Sun%20XY,%20Ouyang%20JM.%20Effects%20of%20physical%20properties%20of%20nano-sized%20hydroxyapatite%20crystals%20on%20cellular%20toxicity%20in%20renal%20epithelial%20cells.%20Mater%20Sci%20Eng%20C%20Mater%20Biol%20Appl.%202019;103:%20109807." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR139">
<span class="label">139.</span><cite>Perry JL, Reuter KG, Luft JC, Pecot CV, Zamboni W, DeSimone JM. Mediating passive tumor accumulation through particle size, tumor type, and location. Nano Lett. 2017;17:2879–86.
</cite> [<a href="https://doi.org/10.1021/acs.nanolett.7b00021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5708115/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28287740/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Perry%20JL,%20Reuter%20KG,%20Luft%20JC,%20Pecot%20CV,%20Zamboni%20W,%20DeSimone%20JM.%20Mediating%20passive%20tumor%20accumulation%20through%20particle%20size,%20tumor%20type,%20and%20location.%20Nano%20Lett.%202017;17:2879%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR140">
<span class="label">140.</span><cite>Ghosh A, Xu W, Gupta N, Gracias DH. Active matter therapeutics. Nano Today. 2020;31: 100836.
</cite> [<a href="https://doi.org/10.1016/j.nantod.2019.100836" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7188019/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32346389/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ghosh%20A,%20Xu%20W,%20Gupta%20N,%20Gracias%20DH.%20Active%20matter%20therapeutics.%20Nano%20Today.%202020;31:%20100836." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR141">
<span class="label">141.</span><cite>Navya PN, Kaphle A, Srinivas SP, Bhargava SK, Rotello VM, Daima HK. Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano Converg. 2019;6:23.
</cite> [<a href="https://doi.org/10.1186/s40580-019-0193-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6626766/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31304563/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Navya%20PN,%20Kaphle%20A,%20Srinivas%20SP,%20Bhargava%20SK,%20Rotello%20VM,%20Daima%20HK.%20Current%20trends%20and%20challenges%20in%20cancer%20management%20and%20therapy%20using%20designer%20nanomaterials.%20Nano%20Converg.%202019;6:23." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR142">
<span class="label">142.</span><cite>Li K, Xu D, Liao H, Xue Y, Sun M, Su H, Xiu X, Zhao T. A review on the generation, discharge, distribution, environmental behavior, and toxicity (especially to microbial aggregates) of nano-TiO(2) in sewage and surface-water and related research prospects. Sci Total Environ. 2022;824: 153866.
</cite> [<a href="https://doi.org/10.1016/j.scitotenv.2022.153866" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35181357/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20K,%20Xu%20D,%20Liao%20H,%20Xue%20Y,%20Sun%20M,%20Su%20H,%20Xiu%20X,%20Zhao%20T.%20A%20review%20on%20the%20generation,%20discharge,%20distribution,%20environmental%20behavior,%20and%20toxicity%20(especially%20to%20microbial%20aggregates)%20of%20nano-TiO(2)%20in%20sewage%20and%20surface-water%20and%20related%20research%20prospects.%20Sci%20Total%20Environ.%202022;824:%20153866." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR143">
<span class="label">143.</span><cite>Murugadoss S, Brassinne F, Sebaihi N, Petry J, Cokic SM, Van Landuyt KL, Godderis L, Mast J, Lison D, Hoet PH, van den Brule S. Agglomeration of titanium dioxide nanoparticles increases toxicological responses <em>in vitro</em> and <em>in vivo</em>. Part Fibre Toxicol. 2020;17: 10.
</cite> [<a href="https://doi.org/10.1186/s12989-020-00341-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7045370/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32101144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Murugadoss%20S,%20Brassinne%20F,%20Sebaihi%20N,%20Petry%20J,%20Cokic%20SM,%20Van%20Landuyt%20KL,%20Godderis%20L,%20Mast%20J,%20Lison%20D,%20Hoet%20PH,%20van%20den%20Brule%20S.%20Agglomeration%20of%20titanium%20dioxide%20nanoparticles%20increases%20toxicological%20responses%20in%20vitro%20and%20in%20vivo.%20Part%20Fibre%20Toxicol.%202020;17:%2010." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR144">
<span class="label">144.</span><cite>Hedberg YS, Wei Z, McCarrick S, Romanovski V, Theodore J, Westin EM, Wagner R, Persson KA, Karlsson HL, Odnevall Wallinder I. Welding fume nanoparticles from solid and flux-cored wires: solubility, toxicity, and role of fluorides. J Hazard Mater. 2021;413: 125273.
</cite> [<a href="https://doi.org/10.1016/j.jhazmat.2021.125273" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33581669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hedberg%20YS,%20Wei%20Z,%20McCarrick%20S,%20Romanovski%20V,%20Theodore%20J,%20Westin%20EM,%20Wagner%20R,%20Persson%20KA,%20Karlsson%20HL,%20Odnevall%20Wallinder%20I.%20Welding%20fume%20nanoparticles%20from%20solid%20and%20flux-cored%20wires:%20solubility,%20toxicity,%20and%20role%20of%20fluorides.%20J%20Hazard%20Mater.%202021;413:%20125273." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Discover Nano are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s11671-025-04328-1"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/11671_2025_Article_4328.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.6 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12361023/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12361023/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12361023%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12361023/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12361023/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12361023/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40824466/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12361023/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40824466/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12361023/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12361023/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="RaIvngxz3lB0GEzs1MVuStKj3Ea98cGwBIbTKUXRtcvuRePiVWeHheuZfRNZmlWb">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
